<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38846354</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Host factors of SARS-CoV-2 in infection, pathogenesis, and long-term effects.</ArticleTitle><Pagination><StartPage>1407261</StartPage><MedlinePgn>1407261</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1407261</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2024.1407261</ELocationID><Abstract><AbstractText>SARS-CoV-2 is the causative virus of the devastating COVID-19 pandemic that results in an unparalleled global health and economic crisis. Despite unprecedented scientific efforts and therapeutic interventions, the fight against COVID-19 continues as the rapid emergence of different SARS-CoV-2 variants of concern and the increasing challenge of long COVID-19, raising a vast demand to understand the pathomechanisms of COVID-19 and its long-term sequelae and develop therapeutic strategies beyond the virus <i>per se</i>. Notably, in addition to the virus itself, the replication cycle of SARS-CoV-2 and clinical severity of COVID-19 is also governed by host factors. In this review, we therefore comprehensively overview the replication cycle and pathogenesis of SARS-CoV-2 from the perspective of host factors and host-virus interactions. We sequentially outline the pathological implications of molecular interactions between host factors and SARS-CoV-2 in multi-organ and multi-system long COVID-19, and summarize current therapeutic strategies and agents targeting host factors for treating these diseases. This knowledge would be key for the identification of new pathophysiological aspects and mechanisms, and the development of actionable therapeutic targets and strategies for tackling COVID-19 and its sequelae.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Zhang, Chen, Tian and Fu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Medical School, West China Hospital and Cancer Center, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Shihan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Medical School, West China Hospital and Cancer Center, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Medical School, West China Hospital and Cancer Center, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Xianghui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Medical School, West China Hospital and Cancer Center, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076662" MajorTopicYN="N">Host Microbial Interactions</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">host factors</Keyword><Keyword MajorTopicYN="N">long-term effects</Keyword><Keyword MajorTopicYN="N">pathology</Keyword><Keyword MajorTopicYN="N">therapeutic targets</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>7</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38846354</ArticleId><ArticleId IdType="pmc">PMC11155306</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2024.1407261</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdi A., AlOtaiby S., Badarin F. A., Khraibi A., Hamdan H., Nader M. (2022). Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy. BioMed. Pharmacother. 146, 112518. doi:&#xa0;10.1016/j.biopha.2021.112518</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.112518</ArticleId><ArticleId IdType="pmc">PMC8654598</ArticleId><ArticleId IdType="pubmed">34906770</ArticleId></ArticleIdList></Reference><Reference><Citation>Agwa S. H. A., Kamel M. M., Elghazaly H., Abd Elsamee A. M., Hafez H., Girgis S. A., et al. . (2021). Association between interferon-lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 variant polymorphisms with the course and outcome of SARS-CoV-2 patients. Genes (Basel) 12. doi:&#xa0;10.3390/genes12060830</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes12060830</ArticleId><ArticleId IdType="pmc">PMC8230293</ArticleId><ArticleId IdType="pubmed">34071309</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S., Uematsu S., Takeuchi O. (2006). Pathogen recognition and innate immunity. Cell 124, 783&#x2013;801. doi:&#xa0;10.1016/j.cell.2006.02.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.02.015</ArticleId><ArticleId IdType="pubmed">16497588</ArticleId></ArticleIdList></Reference><Reference><Citation>Alaeddini M., Etemad-Moghadam S. (2022). SARS-Cov-2 infection in cancer patients, susceptibility, outcome and care. Am. J. Med. Sci. 364, 511&#x2013;520. doi:&#xa0;10.1016/j.amjms.2022.05.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2022.05.017</ArticleId><ArticleId IdType="pmc">PMC9119956</ArticleId><ArticleId IdType="pubmed">35605680</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander M. R., Brice A. M., Jansen van Vuren P., Rootes C. L., Tribolet L., Cowled C., et al. . (2021). Ribosome-profiling reveals restricted post transcriptional expression of antiviral cytokines and transcription factors during SARS-CoV-2 infection. Int. J. Mol. Sci. 22. doi:&#xa0;10.3390/ijms22073392</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22073392</ArticleId><ArticleId IdType="pmc">PMC8036502</ArticleId><ArticleId IdType="pubmed">33806254</ArticleId></ArticleIdList></Reference><Reference><Citation>Amini-Farsani Z., Yadollahi-Farsani M., Arab S., Forouzanfar F., Yadollahi M., Asgharzade S. (2021). Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways. Int. Immunopharmacol 100, 108071. doi:&#xa0;10.1016/j.intimp.2021.108071</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108071</ArticleId><ArticleId IdType="pmc">PMC8378592</ArticleId><ArticleId IdType="pubmed">34482267</ArticleId></ArticleIdList></Reference><Reference><Citation>Amoroso A., Magistroni P., Vespasiano F., Bella A., Bellino S., Puoti F., et al. . (2021). HLA and AB0 polymorphisms may influence SARS-CoV-2 infection and COVID-19 severity. Transplantation 105, 193&#x2013;200. doi:&#xa0;10.1097/TP.0000000000003507</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000003507</ArticleId><ArticleId IdType="pubmed">33141807</ArticleId></ArticleIdList></Reference><Reference><Citation>Amstutz A., Speich B., Mentr&#xe9; F., Rueegg C. S., Belhadi D., Assoumou L., et al. . (2023). Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials. Lancet Respir. Med. 11, 453&#x2013;464. doi:&#xa0;10.1016/S2213-2600(22)00528-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00528-8</ArticleId><ArticleId IdType="pmc">PMC10156140</ArticleId><ArticleId IdType="pubmed">36828006</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbel R., Wolff Sagy Y., Hoshen M., Battat E., Lavie G., Sergienko R., et al. . (2022). Nirmatrelvir use and severe COVID-19 outcomes during the Omicron surge. N Engl. J. Med. 387, 790&#x2013;798. doi:&#xa0;10.1056/NEJMoa2204919</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2204919</ArticleId><ArticleId IdType="pmc">PMC9454652</ArticleId><ArticleId IdType="pubmed">36001529</ArticleId></ArticleIdList></Reference><Reference><Citation>Ata B., Vermeulen N., Mocanu E., Gianaroli L., Lundin K., Rautakallio-Hokkanen S., et al. . (2023). SARS-CoV-2, fertility and assisted reproduction. Hum. Reprod. Update 29, 177&#x2013;196. doi:&#xa0;10.1093/humupd/dmac037</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humupd/dmac037</ArticleId><ArticleId IdType="pmc">PMC9976972</ArticleId><ArticleId IdType="pubmed">36374645</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., Jacquemyn M., Persoons L., Vanstreels E., Pye V. E., Wrobel A. G., et al. . (2023). TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry. Cell 186, 3427&#x2013;3442.e3422. doi:&#xa0;10.1016/j.cell.2023.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.06.005</ArticleId><ArticleId IdType="pmc">PMC10409496</ArticleId><ArticleId IdType="pubmed">37421949</ArticleId></ArticleIdList></Reference><Reference><Citation>Baier C. J., Barrantes F. J. (2023). Role of cholesterol-recognition motifs in the infectivity of SARS-CoV-2 variants. Colloids Surf B Biointerfaces 222, 113090. doi:&#xa0;10.1016/j.colsurfb.2022.113090</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.colsurfb.2022.113090</ArticleId><ArticleId IdType="pmc">PMC9743692</ArticleId><ArticleId IdType="pubmed">36563415</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A. K., Blanco M. R., Bruce E. A., Honson D. D., Chen L. M., Chow A., et al. . (2020). SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses. Cell 183, 1325&#x2013;1339.e1321. doi:&#xa0;10.1016/j.cell.2020.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7543886</ArticleId><ArticleId IdType="pubmed">33080218</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreto E. A., Cruz A. S., Veras F. P., Martins R., Bernardelli R. S., Paiva I. M., et al. . (2023). COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis. Proc. Natl. Acad. Sci. U.S.A. 120, e2217119120. doi:&#xa0;10.1073/pnas.2217119120</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2217119120</ArticleId><ArticleId IdType="pmc">PMC10214153</ArticleId><ArticleId IdType="pubmed">37186819</ArticleId></ArticleIdList></Reference><Reference><Citation>Bills C. J., Xia H., Chen J. Y., Yeung J., Kalveram B. K., Walker D., et al. . (2023). Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism. Emerg. Microbes Infect. 12, 2209208. doi:&#xa0;10.1080/22221751.2023.2209208</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2209208</ArticleId><ArticleId IdType="pmc">PMC10184609</ArticleId><ArticleId IdType="pubmed">37114433</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D., Nilsson-Payant B. E., Liu W. C., Uhl S., Hoagland D., M&#xf8;ller R., et al. . (2020). Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036&#x2013;1045.e1039. doi:&#xa0;10.1016/j.cell.2020.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojkova D., Wagner J. U. G., Shumliakivska M., Aslan G. S., Saleem U., Hansen A., et al. . (2020). SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovasc. Res. 116, 2207&#x2013;2215. doi:&#xa0;10.1093/cvr/cvaa267</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa267</ArticleId><ArticleId IdType="pmc">PMC7543363</ArticleId><ArticleId IdType="pubmed">32966582</ArticleId></ArticleIdList></Reference><Reference><Citation>Boras B., Jones R. M., Anson B. J., Arenson D., Aschenbrenner L., Bakowski M. A., et al. . (2021). Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19. Nat. Commun. 12. doi:&#xa0;10.1038/s41467-021-26239-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26239-2</ArticleId><ArticleId IdType="pmc">PMC8523698</ArticleId><ArticleId IdType="pubmed">34663813</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. (2023). Postacute sequelae of COVID-19 at 2 years. Nat. Med. 29, 2347&#x2013;2357. doi:&#xa0;10.1038/s41591-023-02521-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Xu E., Al-Aly Z. (2021). Kidney outcomes in. J. Am. Soc. Nephrol. 32, 2851&#x2013;2862. doi:&#xa0;10.1681/ASN.2021060734</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021060734</ArticleId><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>Brightling C. E., Evans R. A. (2022). Long COVID: which symptoms can be attributed to SARS-CoV-2 infection? Lancet 400, 411&#x2013;413. doi:&#xa0;10.1016/s0140-6736(22)01385-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(22)01385-x</ArticleId><ArticleId IdType="pmc">PMC9352303</ArticleId><ArticleId IdType="pubmed">35933996</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y., Shi S., Yang F., Yi B., Chen X., Li J., et al. . (2020). Fasting blood glucose level is a predictor of mortality in patients with COVID-19 independent of diabetes history. Diabetes Res. Clin. Pract. 169, 108437. doi:&#xa0;10.1016/j.diabres.2020.108437</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108437</ArticleId><ArticleId IdType="pmc">PMC7482587</ArticleId><ArticleId IdType="pubmed">32920103</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese F., Pezzuto F., Fortarezza F., Hofman P., Kern I., Panizo A., et al. . (2020). Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists. Virchows Arch. 477, 359&#x2013;372. doi:&#xa0;10.1007/s00428-020-02886-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00428-020-02886-6</ArticleId><ArticleId IdType="pmc">PMC7343579</ArticleId><ArticleId IdType="pubmed">32642842</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcagnile M., Forgez P., Iannelli A., Bucci C., Alifano M., Alifano P. (2021). Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein. Biochimie 180, 143&#x2013;148. doi:&#xa0;10.1016/j.biochi.2020.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2020.11.004</ArticleId><ArticleId IdType="pmc">PMC7834737</ArticleId><ArticleId IdType="pubmed">33181224</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos R. K., Camargos V. N., Azar S. R., Haines C. A., Eyzaguirre E. J., Rossi S. L. (2021). SARS-CoV-2 infects hamster testes. Microorganisms 9. doi:&#xa0;10.3390/microorganisms9061318</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9061318</ArticleId><ArticleId IdType="pmc">PMC8235703</ArticleId><ArticleId IdType="pubmed">34204370</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L., Ojha R., Pedro L. D., Djannatian M., Franz J., Kuivanen S., et al. . (2020). Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370, 856&#x2013;860. doi:&#xa0;10.1126/science.abd2985</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao D., Duan L., Huang B., Xiong Y., Zhang G., Huang H. (2023). The SARS-CoV-2 papain-like protease suppresses type I interferon responses by deubiquitinating STING. Sci. Signal 16, eadd0082. doi:&#xa0;10.1126/scisignal.add0082</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.add0082</ArticleId><ArticleId IdType="pubmed">37130168</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlos A. J., Ha D. P., Yeh D. W., Van Krieken R., Tseng C. C., Zhang P., et al. . (2021). The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection. J. Biol. Chem. 296, 100759. doi:&#xa0;10.1016/j.jbc.2021.100759</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100759</ArticleId><ArticleId IdType="pmc">PMC8102082</ArticleId><ArticleId IdType="pubmed">33965375</ArticleId></ArticleIdList></Reference><Reference><Citation>Casari I., Manfredi M., Metharom P., Falasca M. (2021). Dissecting lipid metabolism alterations in SARS-CoV-2. Prog. Lipid Res. 82, 101092. doi:&#xa0;10.1016/j.plipres.2021.101092</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2021.101092</ArticleId><ArticleId IdType="pmc">PMC7869689</ArticleId><ArticleId IdType="pubmed">33571544</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., et al. . (2022). Pathophysiology and mechanism of long COVID: a comprehensive review. Ann. Med. 54, 1473&#x2013;1487. doi:&#xa0;10.1080/07853890.2022.2076901</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Centa A., Fonseca A. S., da Silva Ferreira S. G., Azevedo M. L. V., de Paula C. B. V., Nagashima S., et al. . (2021). Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients. Am. J. Physiol. Lung Cell Mol. Physiol. 320, L405&#x2013;l412. doi:&#xa0;10.1152/ajplung.00457.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00457.2020</ArticleId><ArticleId IdType="pmc">PMC7938642</ArticleId><ArticleId IdType="pubmed">33651636</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan K. K., Dorosky D., Sharma P., Abbasi S. A., Dye J. M., Kranz D. M., et al. . (2020). Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2. Science. 369 (6508), 1261&#x2013;1265. doi:&#xa0;10.1126/science.abc0870</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc0870</ArticleId><ArticleId IdType="pmc">PMC7574912</ArticleId><ArticleId IdType="pubmed">32753553</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Jiang Q., Xia X., Liu K., Yu Z., Tao W., et al. . (2020. a). Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging Cell 19. doi:&#xa0;10.1111/acel.13168</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13168</ArticleId><ArticleId IdType="pmc">PMC7323071</ArticleId><ArticleId IdType="pubmed">32558150</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., Li S., Liu S., Zhang Y., Cui X., Lv L., et al. . (2023. a). Infection of SARS-CoV-2 causes severe pathological changes in mouse testis. J. Genet. Genomics 50, 99&#x2013;107. doi:&#xa0;10.1016/j.jgg.2022.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgg.2022.11.011</ArticleId><ArticleId IdType="pmc">PMC9724560</ArticleId><ArticleId IdType="pubmed">36494057</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., et al. . (2020. b). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507&#x2013;513. doi:&#xa0;10.1016/S0140-6736(20)30211-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Wu M., He Y., Jiang B., He M. L. (2023. b). Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection. Signal Transduct Target Ther. 8, 237. doi:&#xa0;10.1038/s41392-023-01510-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01510-8</ArticleId><ArticleId IdType="pmc">PMC10244875</ArticleId><ArticleId IdType="pubmed">37286535</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Xue Y., Yang J. (2023. c). Gilteritinib: Repurposing of AXL-targeting kinase inhibitors against COVID-19. J. Med. Virol. 95, e28592. doi:&#xa0;10.1002/jmv.28592</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28592</ArticleId><ArticleId IdType="pubmed">36806030</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Zhao X., Zhou H., Zhu H., Jiang S., Wang P. (2023. d). Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses. Nat. Rev. Immunol. 23, 189&#x2013;199. doi:&#xa0;10.1038/s41577-022-00784-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00784-3</ArticleId><ArticleId IdType="pmc">PMC9514166</ArticleId><ArticleId IdType="pubmed">36168054</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Wang C., Feng X., Nie L., Tang M., Zhang H., et al. . (2021). Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis. EMBO J. 40, e107776. doi:&#xa0;10.15252/embj.2021107776</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021107776</ArticleId><ArticleId IdType="pmc">PMC8447597</ArticleId><ArticleId IdType="pubmed">34232536</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L., Hill A. F. (2022). Therapeutically harnessing extracellular vesicles. Nat. Rev. Drug Discovery 21, 379&#x2013;399. doi:&#xa0;10.1038/s41573-022-00410-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-022-00410-w</ArticleId><ArticleId IdType="pubmed">35236964</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherenack E. M., Salazar A. S., Nogueira N. F., Raccamarich P., Rodriguez V. J., Mantero A. M., et al. . (2022). Infection with SARS-CoV-2 is associated with menstrual irregularities among women of reproductive age. PloS One 17, e0276131. doi:&#xa0;10.1371/journal.pone.0276131</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0276131</ArticleId><ArticleId IdType="pmc">PMC9604006</ArticleId><ArticleId IdType="pubmed">36288342</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow J. T., Salmena L. (2020). Prediction and analysis of SARS-CoV-2-targeting microRNA in human lung epithelium. Genes (Basel) 11. doi:&#xa0;10.3390/genes11091002</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes11091002</ArticleId><ArticleId IdType="pmc">PMC7565861</ArticleId><ArticleId IdType="pubmed">32858958</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H., Hou Y., Yang D., Wen L., Shuai H., Yoon C., et al. . (2022). Coronaviruses exploit a host cysteine-aspartic protease for replication. Nature 609, 785&#x2013;792. doi:&#xa0;10.1038/s41586-022-05148-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05148-4</ArticleId><ArticleId IdType="pubmed">35922005</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M. K., Zidar D. A., Bristow M. R., Cameron S. J., Chan T., Harding C. V., et al. . (2021). COVID-19 and cardiovascular disease: From bench to bedside. Circ. Res. 128, 1214&#x2013;1236. doi:&#xa0;10.1161/CIRCRESAHA.121.317997</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.317997</ArticleId><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark D. E., Parikh A., Dendy J. M., Diamond A. B., George-Durrett K., Fish F. A., et al. . (2021). COVID-19 myocardial pathology evaluation in athletes with cardiac magnetic resonance (COMPETE CMR). Circulation 143, 609&#x2013;612. doi:&#xa0;10.1161/CIRCULATIONAHA.120.052573</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.052573</ArticleId><ArticleId IdType="pmc">PMC7864610</ArticleId><ArticleId IdType="pubmed">33332151</ArticleId></ArticleIdList></Reference><Reference><Citation>Coate K. C., Cha J., Shrestha S., Wang W., Gon&#xe7;alves L. M., Alma&#xe7;a J., et al. . (2020). SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not enriched in &#x3b2; cells. Cell Metab. 32, 1028&#x2013;1040.e1024. doi:&#xa0;10.1016/j.cmet.2020.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.11.006</ArticleId><ArticleId IdType="pmc">PMC7664344</ArticleId><ArticleId IdType="pubmed">33207245</ArticleId></ArticleIdList></Reference><Reference><Citation>Codo A. C., Davanzo G. G., Monteiro L. B., de Souza G. F., Muraro S. P., Virgilio-da-Silva J. V., et al. . (2020). Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1&#x3b1;/Glycolysis-dependent axis. Cell Metab. 32, 437&#x2013;446.e435. doi:&#xa0;10.1016/j.cmet.2020.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.07.007</ArticleId><ArticleId IdType="pmc">PMC7367032</ArticleId><ArticleId IdType="pubmed">32697943</ArticleId></ArticleIdList></Reference><Reference><Citation>Colling M. E., Kanthi Y. (2020). COVID-19-associated coagulopathy: An exploration of mechanisms. Vasc. Med. 25, 471&#x2013;478. doi:&#xa0;10.1177/1358863X20932640</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1358863X20932640</ArticleId><ArticleId IdType="pmc">PMC7306998</ArticleId><ArticleId IdType="pubmed">32558620</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte C., Cipponeri E., Roden M. (2024). Diabetes mellitus, energy metabolism, and COVID-19. Endocr. Rev. 45, 281&#x2013;308. doi:&#xa0;10.1210/endrev/bnad032</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endrev/bnad032</ArticleId><ArticleId IdType="pmc">PMC10911957</ArticleId><ArticleId IdType="pubmed">37934800</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa Y., Waldie S., Th&#xe9;paut M., Micciulla S., Moulin M., Fieschi F., et al. . (2021). SARS-CoV-2 spike protein removes lipids from model membranes and interferes with the capacity of high density lipoprotein to exchange lipids. J. Colloid Interface Sci. 602, 732&#x2013;739. doi:&#xa0;10.1016/j.jcis.2021.06.056</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcis.2021.06.056</ArticleId><ArticleId IdType="pmc">PMC8195693</ArticleId><ArticleId IdType="pubmed">34157514</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotton S. J., Belcher J., Rose P., S, K.J., Neal R. D. (2013). The risk of a subsequent cancer diagnosis after herpes zoster infection: primary care database study. Br. J. Cancer 108, 721&#x2013;726. doi:&#xa0;10.1038/bjc.2013.13</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.2013.13</ArticleId><ArticleId IdType="pmc">PMC3593559</ArticleId><ArticleId IdType="pubmed">23361054</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui J., Li F., Shi Z. L. (2019). Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 17, 181&#x2013;192. doi:&#xa0;10.1038/s41579-018-0118-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0118-9</ArticleId><ArticleId IdType="pmc">PMC7097006</ArticleId><ArticleId IdType="pubmed">30531947</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai P., Qiao F., Chen Y., Chan D. Y. L., Yim H. C. H., Fok K. L., et al. . (2023). SARS-CoV-2 and male infertility: from short- to long-term impacts. J. Endocrinol. Invest. 46, 1491&#x2013;1507. doi:&#xa0;10.1007/s40618-023-02055-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-023-02055-x</ArticleId><ArticleId IdType="pmc">PMC10013302</ArticleId><ArticleId IdType="pubmed">36917421</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniloski Z., Jordan T. X., Wessels H. H., Hoagland D. A., Kasela S., Legut M., et al. . (2021). Identification of required host factors for SARS-CoV-2 infection in human cells. Cell 184, 92&#x2013;105.e116. doi:&#xa0;10.1016/j.cell.2020.10.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.030</ArticleId><ArticleId IdType="pmc">PMC7584921</ArticleId><ArticleId IdType="pubmed">33147445</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies J., Randeva H. S., Chatha K., Hall M., Spandidos D. A., Karteris E., et al. . (2020). Neuropilin&#x2212;1 as a new potential SARS&#x2212;CoV&#x2212;2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID&#x2212;19. Mol. Med. Rep. 22, 4221&#x2013;4226. doi:&#xa0;10.3892/mmr.2020.11510</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2020.11510</ArticleId><ArticleId IdType="pmc">PMC7533503</ArticleId><ArticleId IdType="pubmed">33000221</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., McCorkell L., Vogel J. M., Topol E. J. (2023). Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133&#x2013;146. doi:&#xa0;10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice F. G., Tovar-Moll F., Moll J., Munoz D. P., Ferreira S. T. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the central nervous system. Trends Neurosci. 43, 355&#x2013;357. doi:&#xa0;10.1016/j.tins.2020.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7172664</ArticleId><ArticleId IdType="pubmed">32359765</ArticleId></ArticleIdList></Reference><Reference><Citation>Delval L., Hantute-Ghesquier A., Sencio V., Flaman J. M., Robil C., Angulo F. S., et al. . (2023). Removal of senescent cells reduces the viral load and attenuates pulmonary and systemic inflammation in SARS-CoV-2-infected, aged hamsters. Nat. Aging 3, 829&#x2013;845. doi:&#xa0;10.1038/s43587-023-00442-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-023-00442-w</ArticleId><ArticleId IdType="pmc">PMC10353934</ArticleId><ArticleId IdType="pubmed">37414987</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira L. G., de Souza Angelo Y., Yamamoto P., Carregari V. C., Crunfli F., Reis-de-Oliveira G., et al. . (2022). SARS-CoV-2 infection impacts carbon metabolism and depends on glutamine for replication in Syrian hamster astrocytes. J. Neurochem. 163, 113&#x2013;132. doi:&#xa0;10.1111/jnc.15679</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15679</ArticleId><ArticleId IdType="pmc">PMC9350388</ArticleId><ArticleId IdType="pubmed">35880385</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey L., Chakraborty S., Mukhopadhyay A. (2020). Machine learning techniques for sequence-based prediction of viral-host interactions between SARS-CoV-2 and human proteins. BioMed. J. 43, 438&#x2013;450. doi:&#xa0;10.1016/j.bj.2020.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bj.2020.08.003</ArticleId><ArticleId IdType="pmc">PMC7470713</ArticleId><ArticleId IdType="pubmed">33036956</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond M. S., Kanneganti T. D. (2022). Innate immunity: the first line of defense against SARS-CoV-2. Nat. Immunol. 23, 165&#x2013;176. doi:&#xa0;10.1038/s41590-021-01091-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01091-0</ArticleId><ArticleId IdType="pmc">PMC8935980</ArticleId><ArticleId IdType="pubmed">35105981</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong M., Zhang J., Ma X., Tan J., Chen L., Liu S., et al. . (2020). ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. BioMed. Pharmacother. 131, 110678. doi:&#xa0;10.1016/j.biopha.2020.110678</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110678</ArticleId><ArticleId IdType="pmc">PMC7444942</ArticleId><ArticleId IdType="pubmed">32861070</ArticleId></ArticleIdList></Reference><Reference><Citation>Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., et al. . (2000). A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87, E1&#x2013;E9. doi:&#xa0;10.1161/01.RES.87.5.e1</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.87.5.e1</ArticleId><ArticleId IdType="pubmed">10969042</ArticleId></ArticleIdList></Reference><Reference><Citation>Donyavi T., Bokharaei-Salim F., Baghi H. B., Khanaliha K., Alaei Janat-Makan M., Karimi B., et al. . (2021). Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC. Int. Immunopharmacol 97, 107641. doi:&#xa0;10.1016/j.intimp.2021.107641</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107641</ArticleId><ArticleId IdType="pmc">PMC8023203</ArticleId><ArticleId IdType="pubmed">33895478</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugerdil A., Semenzato L., Weill A., Zureik M., Flahault A. (2023). Severe SARS-CoV-2 infection as a marker of undiagnosed cancer: a population-based study. Sci. Rep. 13. doi:&#xa0;10.1038/s41598-023-36013-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-36013-7</ArticleId><ArticleId IdType="pmc">PMC10227779</ArticleId><ArticleId IdType="pubmed">37253848</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberhardt N., Noval M. G., Kaur R., Sajja S., Amadori L., Das D., et al. . (2023). SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels. Nat. Cardiovasc. Res. 2 (10), 899&#x2013;916. doi:&#xa0;10.1038/s44161-023-00336-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44161-023-00336-5</ArticleId><ArticleId IdType="pmc">PMC10702930</ArticleId><ArticleId IdType="pubmed">38076343</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Maradny Y. A., Rubio-Casillas A., Mohamed K. I., Uversky V. N., Redwan E. M. (2023). Intrinsic factors behind long-COVID: II. SARS-CoV-2, extracellular vesicles, and neurological disorders. J. Cell Biochem. 124, 1466&#x2013;1485. doi:&#xa0;10.1002/jcb.30486</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.30486</ArticleId><ArticleId IdType="pubmed">37801299</ArticleId></ArticleIdList></Reference><Reference><Citation>El Zein S., Chehab O., Kanj A., Akrawe S., Alkassis S., Mishra T., et al. . (2021). SARS-CoV-2 infection: Initial viral load (iVL) predicts severity of illness/outcome, and declining trend of iVL in hospitalized patients corresponds with slowing of the pandemic. PloS One 16, e0255981. doi:&#xa0;10.1371/journal.pone.0255981</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255981</ArticleId><ArticleId IdType="pmc">PMC8445469</ArticleId><ArticleId IdType="pubmed">34529675</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst C., Morton C. C. (2013). Identification and function of. Front. Cell Neurosci. 7. doi:&#xa0;10.3389/fncel.2013.00168</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00168</ArticleId><ArticleId IdType="pmc">PMC3788346</ArticleId><ArticleId IdType="pubmed">24106460</ArticleId></ArticleIdList></Reference><Reference><Citation>Essalmani R., Jain J., Susan-Resiga D., Andr&#xe9;o U., Evagelidis A., Derbali R. M., et al. . (2022). Distinctive roles of furin and TMPRSS2 in SARS-CoV-2 infectivity. J. Virol. 96, e0012822. doi:&#xa0;10.1128/jvi.00128-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00128-22</ArticleId><ArticleId IdType="pmc">PMC9044946</ArticleId><ArticleId IdType="pubmed">35343766</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans J. P., Liu S. L. (2021). Role of host factors in SARS-CoV-2 entry. J. Biol. Chem. 297, 100847. doi:&#xa0;10.1016/j.jbc.2021.100847</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100847</ArticleId><ArticleId IdType="pmc">PMC8160279</ArticleId><ArticleId IdType="pubmed">34058196</ArticleId></ArticleIdList></Reference><Reference><Citation>Faivre E. J., McDaniel K. F., Albert D. H., Mantena S. R., Plotnik J. P., Wilcox D., et al. . (2020). Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer. Nature. 578 (7794), 306&#x2013;310. doi:&#xa0;10.1038/s41586-020-1930-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-1930-8</ArticleId><ArticleId IdType="pubmed">31969702</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajnzylber J., Regan J., Coxen K., Corry H., Wong C., Rosenthal A., et al. . (2020). SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat. Commun. 11. doi:&#xa0;10.1038/s41467-020-19057-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19057-5</ArticleId><ArticleId IdType="pmc">PMC7603483</ArticleId><ArticleId IdType="pubmed">33127906</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Q., He X., Zheng X., Fu Y., Fu T., Luo J., et al. . (2023). Verifying AXL and putative proteins as SARS-CoV-2 receptors by DnaE intein-based rapid cell-cell fusion assay. J. Med. Virol. 95, e28953. doi:&#xa0;10.1002/jmv.28953</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28953</ArticleId><ArticleId IdType="pubmed">37461287</ArticleId></ArticleIdList></Reference><Reference><Citation>Feld J. J., Kandel C., Biondi M. J., Kozak R. A., Zahoor M. A., Lemieux C., et al. . (2021). Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial. Lancet Respir. Med. 9, 498&#x2013;510. doi:&#xa0;10.1016/S2213-2600(20)30566-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30566-X</ArticleId><ArticleId IdType="pmc">PMC7906707</ArticleId><ArticleId IdType="pubmed">33556319</ArticleId></ArticleIdList></Reference><Reference><Citation>Follis K. E., York J., Nunberg J. H. (2006). Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry. Virology 350, 358&#x2013;369. doi:&#xa0;10.1016/j.virol.2006.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2006.02.003</ArticleId><ArticleId IdType="pmc">PMC7111780</ArticleId><ArticleId IdType="pubmed">16519916</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser B. J., Beldar S., Seitova A., Hutchinson A., Mannar D., Li Y., et al. . (2022). Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation. Nat. Chem. Biol. 18, 963&#x2013;971. doi:&#xa0;10.1038/s41589-022-01059-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41589-022-01059-7</ArticleId><ArticleId IdType="pubmed">35676539</ArticleId></ArticleIdList></Reference><Reference><Citation>Frolov I., Agback T., Palchevska O., Dominguez F., Lomzov A., Agback P., et al. . (2023). All domains of SARS-CoV-2 nsp1 determine translational shutoff and cytotoxicity of the protein. J. Virol. 97, e0186522. doi:&#xa0;10.1128/jvi.01865-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01865-22</ArticleId><ArticleId IdType="pmc">PMC10062135</ArticleId><ArticleId IdType="pubmed">36847528</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu J., Zhou B., Zhang L., Balaji K. S., Wei C., Liu X., et al. . (2020). Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Mol. Biol. Rep. 47, 4383&#x2013;4392. doi:&#xa0;10.1007/s11033-020-05478-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-020-05478-4</ArticleId><ArticleId IdType="pmc">PMC7224351</ArticleId><ArticleId IdType="pubmed">32410141</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung T. S., Liu D. X. (2019). Human coronavirus: Host-pathogen interaction. Annu. Rev. Microbiol. 73, 529&#x2013;557. doi:&#xa0;10.1146/annurev-micro-020518-115759</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-micro-020518-115759</ArticleId><ArticleId IdType="pubmed">31226023</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y. M., Xu G., Wang B., Liu B. C. (2021). Cytokine storm syndrome in coronavirus disease 2019: A narrative review. J. Intern. Med. 289, 147&#x2013;161. doi:&#xa0;10.1111/joim.13144</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13144</ArticleId><ArticleId IdType="pmc">PMC7404514</ArticleId><ArticleId IdType="pubmed">32696489</ArticleId></ArticleIdList></Reference><Reference><Citation>Garreta E., Prado P., Stanifer M. L., Monteil V., Marco A., Ullate-Agote A., et al. . (2022). A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells. Cell Metab. 34, 857&#x2013;873.e859. doi:&#xa0;10.1016/j.cmet.2022.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2022.04.009</ArticleId><ArticleId IdType="pmc">PMC9097013</ArticleId><ArticleId IdType="pubmed">35561674</ArticleId></ArticleIdList></Reference><Reference><Citation>Gates B. (2020). Responding to COVID-19 - a once-in-a-century pandemic? N Engl. J. Med. 382, 1677&#x2013;1679. doi:&#xa0;10.1056/NEJMp2003762</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2003762</ArticleId><ArticleId IdType="pubmed">32109012</ArticleId></ArticleIdList></Reference><Reference><Citation>George M. S., Sanchez J., Rollings C., Fear D., Irving P., Sinclair L. V., et al. . (2023). Extracellular vesicles in COVID-19 convalescence can regulate T cell metabolism and function. iScience 26, 107280. doi:&#xa0;10.1016/j.isci.2023.107280</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.107280</ArticleId><ArticleId IdType="pmc">PMC10371842</ArticleId><ArticleId IdType="pubmed">37520724</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil-Etayo F. J., Su&#xe0;rez-Fern&#xe1;ndez P., Cabrera-Marante O., Arroyo D., Garcinu&#xf1;o S., Naranjo L., et al. . (2021). T-helper cell subset response is a determining factor in COVID-19 progression. Front. Cell Infect. Microbiol. 11. doi:&#xa0;10.3389/fcimb.2021.624483</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.624483</ArticleId><ArticleId IdType="pmc">PMC7952877</ArticleId><ArticleId IdType="pubmed">33718270</ArticleId></ArticleIdList></Reference><Reference><Citation>Gioia U., Tavella S., Mart&#xed;nez-Orellana P., Cicio G., Colliva A., Ceccon M., et al. . (2023). SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence. Nat. Cell Biol. 25, 550&#x2013;564. doi:&#xa0;10.1038/s41556-023-01096-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-023-01096-x</ArticleId><ArticleId IdType="pmc">PMC10104783</ArticleId><ArticleId IdType="pubmed">36894671</ArticleId></ArticleIdList></Reference><Reference><Citation>Glowacka I., Bertram S., Muller M. A., Allen P., Soilleux E., Pfefferle S., et al. . (2011). Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J. Virol. 85, 4122&#x2013;4134. doi:&#xa0;10.1128/JVI.02232-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02232-10</ArticleId><ArticleId IdType="pmc">PMC3126222</ArticleId><ArticleId IdType="pubmed">21325420</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon D. E., Jang G. M., Bouhaddou M., Xu J., Obernier K., White K. M., et al. . (2020). A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459&#x2013;468. doi:&#xa0;10.1038/s41586-020-2286-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2286-9</ArticleId><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Gori Savellini G., Anichini G., Gandolfo C., Cusi M. G. (2021). SARS-CoV-2 N protein targets TRIM25-mediated RIG-I activation to suppress innate immunity. Viruses 13. doi:&#xa0;10.3390/v13081439</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13081439</ArticleId><ArticleId IdType="pmc">PMC8402637</ArticleId><ArticleId IdType="pubmed">34452305</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M., Tao W., Flavell R. A., Zhu S. (2021). Potential intestinal infection and faecal-oral transmission of SARS-CoV-2. Nat. Rev. Gastroenterol. Hepatol. 18, 269&#x2013;283. doi:&#xa0;10.1038/s41575-021-00416-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-021-00416-6</ArticleId><ArticleId IdType="pmc">PMC7883337</ArticleId><ArticleId IdType="pubmed">33589829</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J., Yatim N., Barnabei L., Corneau A., Boussier J., Smith N., et al. . (2020). Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718&#x2013;724. doi:&#xa0;10.1126/science.abc6027</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafiane A. (2020). SARS-CoV-2 and the cardiovascular system. Clin. Chim. Acta 510, 311&#x2013;316. doi:&#xa0;10.1016/j.cca.2020.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.07.019</ArticleId><ArticleId IdType="pmc">PMC7363601</ArticleId><ArticleId IdType="pubmed">32681935</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn F., Wangen C., H&#xe4;ge S., Peter A. S., Dobler G., Hurst B., et al. . (2020). IMU-838, a developmental DHODH inhibitor in phase II for autoimmune disease, shows anti-SARS-CoV-2 and broad-spectrum antiviral efficacy in vitro . Viruses 12. doi:&#xa0;10.3390/v12121394</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12121394</ArticleId><ArticleId IdType="pmc">PMC7762174</ArticleId><ArticleId IdType="pubmed">33291455</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M. L., Lely A. T., Navis G., van Goor H. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631&#x2013;637. doi:&#xa0;10.1002/path.1570</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L., Zheng Y., Deng J., Nan M. L., Xiao Y., Zhuang M. W., et al. . (2022). SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy. J. Med. Virol. 94, 5174&#x2013;5188. doi:&#xa0;10.1002/jmv.27965</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27965</ArticleId><ArticleId IdType="pmc">PMC9350412</ArticleId><ArticleId IdType="pubmed">35765167</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannun Y. A., Obeid L. M. (2018). Sphingolipids and their metabolism in physiology and disease. Nat. Rev. Mol. Cell Biol. 19, 175&#x2013;191. doi:&#xa0;10.1038/nrm.2017.107</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.107</ArticleId><ArticleId IdType="pmc">PMC5902181</ArticleId><ArticleId IdType="pubmed">29165427</ArticleId></ArticleIdList></Reference><Reference><Citation>He X., Liu C., Peng J., Li Z., Li F., Wang J., et al. . (2021). COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors. Signal Transduct Target Ther. 6, 427. doi:&#xa0;10.1038/s41392-021-00822-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00822-x</ArticleId><ArticleId IdType="pmc">PMC8674414</ArticleId><ArticleId IdType="pubmed">34916489</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez P. V., Chen L., Zhang R., Jackups R., Nelson D. M., He M. (2023). The effects of preconception and early gestation SARS-CoV-2 infection on pregnancy outcomes and placental pathology. Ann. Diagn. Pathol. 62, 152076. doi:&#xa0;10.1016/j.anndiagpath.2022.152076</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anndiagpath.2022.152076</ArticleId><ArticleId IdType="pmc">PMC9721196</ArticleId><ArticleId IdType="pubmed">36495735</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickson L. J., Langhi Prata L. G. P., Bobart S. A., Evans T. K., Giorgadze N., Hashmi S. K., et al. . (2019). Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine 47, 446&#x2013;456. doi:&#xa0;10.1016/j.ebiom.2019.08.069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.08.069</ArticleId><ArticleId IdType="pmc">PMC6796530</ArticleId><ArticleId IdType="pubmed">31542391</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikmet F., M&#xe9;ar L., Edvinsson &#xc5;., Micke P., Uhl&#xe9;n M., Lindskog C. (2020). The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 16, e9610. doi:&#xa0;10.15252/msb.20209610</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20209610</ArticleId><ArticleId IdType="pmc">PMC7383091</ArticleId><ArticleId IdType="pubmed">32715618</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill J. M., Lukiw W. J. (2022). microRNA, the innate-immune system and SARS-CoV-2. Front. Cell Infect. Microbiol. 12. doi:&#xa0;10.3389/fcimb.2022.887800</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.887800</ArticleId><ArticleId IdType="pmc">PMC9245018</ArticleId><ArticleId IdType="pubmed">35782132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., et al. . (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271&#x2013;280.e278. doi:&#xa0;10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann H. H., Sanchez-Rivera F. J., Schneider W. M., Luna J. M., Soto-Feliciano Y. M., Ashbrook A. W., et al. . (2021). Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors. Cell Host Microbe 29, 267&#x2013;280.e265. doi:&#xa0;10.1016/j.chom.2020.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.12.009</ArticleId><ArticleId IdType="pmc">PMC7833927</ArticleId><ArticleId IdType="pubmed">33357464</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q., Xie Q., Shi C. C., Xiang X. G., Lin L. Y., Gong B. D., et al. . (2009). Expression of angiotensin-converting enzyme 2 in CCL4-induced rat liver fibrosis. Int. J. Mol. Med. 23, 717&#x2013;723. doi:&#xa0;10.3892/ijmm_00000185</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm_00000185</ArticleId><ArticleId IdType="pubmed">19424597</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Zhao P., Tang D., Zhu T., Han R., Zhan C., et al. . (2020). Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc. Imaging 13, 2330&#x2013;2339. doi:&#xa0;10.1016/j.jcmg.2020.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Irham L. M., Chou W. H., Calkins M. J., Adikusuma W., Hsieh S. L., Chang W. C. (2020). Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents. Biochem. Biophys. Res. Commun. 529, 263&#x2013;269. doi:&#xa0;10.1016/j.bbrc.2020.05.179</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.05.179</ArticleId><ArticleId IdType="pmc">PMC7831678</ArticleId><ArticleId IdType="pubmed">32703421</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C. B., Farzan M., Chen B., Choe H. (2022). Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23, 3&#x2013;20. doi:&#xa0;10.1038/s41580-021-00418-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarinejad-Farsangi S., Jazi M. M., Rostamzadeh F., Hadizadeh M. (2020). High affinity of host human microRNAs to SARS-CoV-2 genome: An in silico analysis. Noncoding RNA Res. 5, 222&#x2013;231. doi:&#xa0;10.1016/j.ncrna.2020.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncrna.2020.11.005</ArticleId><ArticleId IdType="pmc">PMC7680021</ArticleId><ArticleId IdType="pubmed">33251388</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen J., Reimer K. C., Nagai J. S., Varghese F. S., Overheul G. J., de Beer M., et al. . (2022). SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell 29, 217&#x2013;231.e218. doi:&#xa0;10.1016/j.stem.2021.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.12.010</ArticleId><ArticleId IdType="pmc">PMC8709832</ArticleId><ArticleId IdType="pubmed">35032430</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayk Bernal A., Gomes da Silva M. M., Musungaie D. B., Kovalchuk E., Gonzalez A., Delos Reyes V., et al. . (2022). Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients. N Engl. J. Med. 386, 509&#x2013;520. doi:&#xa0;10.1056/NEJMoa2116044</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2116044</ArticleId><ArticleId IdType="pmc">PMC8693688</ArticleId><ArticleId IdType="pubmed">34914868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji M., Li M., Sun L., Zhao H., Li Y., Zhou L., et al. . (2022). VMP1 and TMEM41B are essential for DMV formation during &#x3b2;-coronavirus infection. J. Cell Biol. 221, e202112081. doi:&#xa0;10.1083/jcb.202112081</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202112081</ArticleId><ArticleId IdType="pmc">PMC9097365</ArticleId><ArticleId IdType="pubmed">35536318</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang F., Tang X., Tang C., Hua Z., Ke M., Wang C., et al. . (2021). HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA. J. Hematol. Oncol. 14, 54. doi:&#xa0;10.1186/s13045-021-01066-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-021-01066-6</ArticleId><ArticleId IdType="pmc">PMC8017865</ArticleId><ArticleId IdType="pubmed">33794982</ArticleId></ArticleIdList></Reference><Reference><Citation>Jose R. J., Manuel A. (2020). COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir. Med. 8, e46&#x2013;e47. doi:&#xa0;10.1016/S2213-2600(20)30216-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30216-2</ArticleId><ArticleId IdType="pmc">PMC7185942</ArticleId><ArticleId IdType="pubmed">32353251</ArticleId></ArticleIdList></Reference><Reference><Citation>Jothimani D., Venugopal R., Abedin M. F., Kaliamoorthy I., Rela M. (2020). COVID-19 and the liver. J. Hepatol. 73, 1231&#x2013;1240. doi:&#xa0;10.1016/j.jhep.2020.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.06.006</ArticleId><ArticleId IdType="pmc">PMC7295524</ArticleId><ArticleId IdType="pubmed">32553666</ArticleId></ArticleIdList></Reference><Reference><Citation>Justice J. N., Nambiar A. M., Tchkonia T., LeBrasseur N. K., Pascual R., Hashmi S. K., et al. . (2019). Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine 40, 554&#x2013;563. doi:&#xa0;10.1016/j.ebiom.2018.12.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.12.052</ArticleId><ArticleId IdType="pmc">PMC6412088</ArticleId><ArticleId IdType="pubmed">30616998</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko N., Kuo H. H., Boucau J., Farmer J. R., Allard-Chamard H., Mahajan V. S., et al. . (2020). Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19. Cell 183, 143&#x2013;157.e113. doi:&#xa0;10.1016/j.cell.2020.08.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.025</ArticleId><ArticleId IdType="pmc">PMC7437499</ArticleId><ArticleId IdType="pubmed">32877699</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Y., Shi Y., Xu S. (2023). Arbidol: The current demand, strategies, and antiviral mechanisms. Immun. Inflammation Dis. 11, e984. doi:&#xa0;10.1002/iid3.984</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.984</ArticleId><ArticleId IdType="pmc">PMC10461429</ArticleId><ArticleId IdType="pubmed">37647451</ArticleId></ArticleIdList></Reference><Reference><Citation>Kee J., Thudium S., Renner D. M., Glastad K., Palozola K., Zhang Z., et al. . (2022). SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry. Nature 610, 381&#x2013;388. doi:&#xa0;10.1038/s41586-022-05282-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05282-z</ArticleId><ArticleId IdType="pmc">PMC9533993</ArticleId><ArticleId IdType="pubmed">36198800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehrer T., Cupic A., Ye C., Yildiz S., Bouhaddou M., Crossland N. A., et al. . (2023). Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis. Cell Host Microbe 31, 1668&#x2013;1684.e1612. doi:&#xa0;10.1016/j.chom.2023.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2023.08.003</ArticleId><ArticleId IdType="pmc">PMC10750313</ArticleId><ArticleId IdType="pubmed">37738983</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A. A.-O., Khalid Z., Zahid H., Yousaf M. A., Shakoori A. R.. (2022). A computational and bioinformatic analysis of ACE2: an elucidation of its dual role in COVID-19 pathology and finding its associated partners as potential therapeutic targets. J. Biomol. Struct. Dyn. 40 (4), 1813&#x2013;1829. doi:&#xa0;10.1080/07391102.2020.1833760</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1833760</ArticleId><ArticleId IdType="pmc">PMC7596956</ArticleId><ArticleId IdType="pubmed">33073716</ArticleId></ArticleIdList></Reference><Reference><Citation>Khreefa Z., Barbier M. T., Koksal A. R., Love G., Del Valle L. (2023). Pathogenesis and mechanisms of SARS-coV-2 infection in the intestine, liver, and pancreas. Cells 12. doi:&#xa0;10.3390/cells12020262</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12020262</ArticleId><ArticleId IdType="pmc">PMC9856332</ArticleId><ArticleId IdType="pubmed">36672197</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D. K., Weller B., Lin C. W., Sheykhkarimli D., Knapp J. J., Dugied G., et al. . (2023). A proteome-scale map of the SARS-CoV-2-human contactome. Nat. Biotechnol. 41, 140&#x2013;149. doi:&#xa0;10.1038/s41587-022-01475-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-022-01475-z</ArticleId><ArticleId IdType="pmc">PMC9849141</ArticleId><ArticleId IdType="pubmed">36217029</ArticleId></ArticleIdList></Reference><Reference><Citation>Klemm T., Ebert G., Calleja D. J., Allison C. C., Richardson L. W., Bernardini J. P., et al. . (2020). Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2. EMBO J. 39, e106275. doi:&#xa0;10.15252/embj.2020106275</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106275</ArticleId><ArticleId IdType="pmc">PMC7461020</ArticleId><ArticleId IdType="pubmed">32845033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudryavtsev I. V., Arsentieva N. A., Korobova Z. R., Isakov D. V., Rubinstein A. A., Batsunov O. K., et al. . (2022). Heterogenous CD8+ T cell maturation and &#x2018;polarization&#x2019; in acute and convalescent COVID-19 patients. Viruses 14. doi:&#xa0;10.3390/v14091906</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14091906</ArticleId><ArticleId IdType="pmc">PMC9504186</ArticleId><ArticleId IdType="pubmed">36146713</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuppe C., Ibrahim M. M., Kranz J., Zhang X., Ziegler S., Perales-Pat&#xf3;n J., et al. . (2021). Decoding myofibroblast origins in human kidney fibrosis. Nature 589, 281&#x2013;286. doi:&#xa0;10.1038/s41586-020-2941-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2941-1</ArticleId><ArticleId IdType="pmc">PMC7611626</ArticleId><ArticleId IdType="pubmed">33176333</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C. C., Hsu C. K., Yen M. Y., Lee P. I., Ko W. C., Hsueh P. R. (2023). Long COVID: An inevitable sequela of SARS-CoV-2 infection. J. Microbiol. Immunol. Infect. 56, 1&#x2013;9. doi:&#xa0;10.1016/j.jmii.2022.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2022.10.003</ArticleId><ArticleId IdType="pmc">PMC9576029</ArticleId><ArticleId IdType="pubmed">36283919</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam S. M., Zhang C., Wang Z., Ni Z., Zhang S., Yang S., et al. . (2021). A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19. Nat. Metab. 3, 909&#x2013;922. doi:&#xa0;10.1038/s42255-021-00425-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00425-4</ArticleId><ArticleId IdType="pubmed">34158670</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert D. W., Yarski M., Warner F. J., Thornhill P., Parkin E. T., Smith A. I., et al. . (2005). Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J. Biol. Chem. 280, 30113&#x2013;30119. doi:&#xa0;10.1074/jbc.M505111200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M505111200</ArticleId><ArticleId IdType="pmc">PMC8062222</ArticleId><ArticleId IdType="pubmed">15983030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanjanian H., Moazzam-Jazi M., Hedayati M., Akbarzadeh M., Guity K., Sedaghati-Khayat B., et al. . (2021). SARS-CoV-2 infection susceptibility influenced by ACE2 genetic polymorphisms: insights from Tehran Cardio-Metabolic Genetic Study. Sci. Rep. 11. doi:&#xa0;10.1038/s41598-020-80325-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80325-x</ArticleId><ArticleId IdType="pmc">PMC7810897</ArticleId><ArticleId IdType="pubmed">33452303</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini P. E., Laghi-Pasini F., Boutjdir M., Capecchi P. L. (2019). Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat. Rev. Immunol. 19, 63&#x2013;64. doi:&#xa0;10.1038/s41577-018-0098-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0098-z</ArticleId><ArticleId IdType="pubmed">30552387</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Lee Y. S., Choi Y., Son A., Park Y., Lee K.-M., et al. . (2021). The SARS-coV-2 RNA interactome. Mol. Cell. 81 (13), 2838&#x2013;2850.e2836. doi:&#xa0;10.1016/j.molcel.2021.04.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.04.022</ArticleId><ArticleId IdType="pmc">PMC8075806</ArticleId><ArticleId IdType="pubmed">33989516</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei H. Y., Ding Y. H., Nie K., Dong Y. M., Xu J. H., Yang M. L., et al. . (2021. a). Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. BioMed. Pharmacother. 133, 111064. doi:&#xa0;10.1016/j.biopha.2020.111064</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.111064</ArticleId><ArticleId IdType="pmc">PMC7700011</ArticleId><ArticleId IdType="pubmed">33378966</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei J., Ma-Lauer Y., Han Y., Thoms M., Buschauer R., Jores J., et al. . (2021. b). The SARS-unique domain (SUD) of SARS-CoV and SARS-CoV-2 interacts with human Paip1 to enhance viral RNA translation. EMBO J. 40 (11), e102277. doi:&#xa0;10.15252/embj.2019102277</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2019102277</ArticleId><ArticleId IdType="pmc">PMC8167360</ArticleId><ArticleId IdType="pubmed">33876849</ArticleId></ArticleIdList></Reference><Reference><Citation>Letko M., Marzi A., Munster V. (2020). Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 5, 562&#x2013;569. doi:&#xa0;10.1038/s41564-020-0688-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0688-y</ArticleId><ArticleId IdType="pmc">PMC7095430</ArticleId><ArticleId IdType="pubmed">32094589</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y. C., Bai W. Z., Hashikawa T. (2020. b). The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J. Med. Virol. 92, 552&#x2013;555. doi:&#xa0;10.1002/jmv.25728</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25728</ArticleId><ArticleId IdType="pmc">PMC7228394</ArticleId><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y. C., Bai W. Z., Hirano N., Hayashida T., Hashikawa T. (2012). Coronavirus infection of rat dorsal root ganglia: ultrastructural characterization of viral replication, transfer, and the early response of satellite cells. Virus Res. 163, 628&#x2013;635. doi:&#xa0;10.1016/j.virusres.2011.12.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2011.12.021</ArticleId><ArticleId IdType="pmc">PMC7114492</ArticleId><ArticleId IdType="pubmed">22248641</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C. J., Chang S. C. (2023). SARS-CoV-2 spike S2-specific neutralizing antibodies. Emerg. Microbes Infect. 12, 2220582. doi:&#xa0;10.1080/22221751.2023.2220582</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2220582</ArticleId><ArticleId IdType="pmc">PMC10274517</ArticleId><ArticleId IdType="pubmed">37254830</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Jin M., Bao P., Zhao W., Zhang S. (2020. a). Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw. Open 3, e208292. doi:&#xa0;10.1001/jamanetworkopen.2020.8292</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.8292</ArticleId><ArticleId IdType="pmc">PMC7206502</ArticleId><ArticleId IdType="pubmed">32379329</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T. W., Kenney A. D., Park J. G., Fiches G. N., Liu H., Zhou D., et al. . (2022. a). SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-&#x3ba;B signaling. Front. Immunol. 13. doi:&#xa0;10.3389/fimmu.2022.1007089</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1007089</ArticleId><ArticleId IdType="pmc">PMC9513374</ArticleId><ArticleId IdType="pubmed">36177032</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Peng M., Chen P., Liu C., Hu A., Zhang Y., et al. . (2022. b). Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry. Cell Metab. 34 (3), 424&#x2013;440.e427. doi:&#xa0;10.1016/j.cmet.2022.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2022.01.008</ArticleId><ArticleId IdType="pmc">PMC8832557</ArticleId><ArticleId IdType="pubmed">35150639</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Sottas C. M., Chen H. Y., Li Y., Cui H., Villano J. S., et al. . (2023. b). SARS-CoV-2 enters human leydig cells and affects testosterone production in vitro . Cells 12. doi:&#xa0;10.3390/cells12081198</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12081198</ArticleId><ArticleId IdType="pmc">PMC10136776</ArticleId><ArticleId IdType="pubmed">37190107</ArticleId></ArticleIdList></Reference><Reference><Citation>Li A., Zhang B., Zhao K., Yin Z., Teng Y., Zhang L., et al. . (2023. a). SARS-CoV-2 nsp13 restricts episomal DNA transcription without affecting chromosomal DNA. J. Virol. 97, e0051223. doi:&#xa0;10.1128/jvi.00512-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00512-23</ArticleId><ArticleId IdType="pmc">PMC10373537</ArticleId><ArticleId IdType="pubmed">37347173</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S. P. (2023). Targeting SARS-CoV-2 and host cell receptor interactions. Antiviral Res. 210, 105514. doi:&#xa0;10.1016/j.antiviral.2022.105514</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2022.105514</ArticleId><ArticleId IdType="pmc">PMC9792186</ArticleId><ArticleId IdType="pubmed">36581047</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G., Cooley M. A., Jarnicki A. G., Borghuis T., Nair P. M., Tjin G., et al. . (2019). Fibulin-1c regulates transforming growth factor-&#x3b2; activation in pulmonary tissue fibrosis. JCI Insight 5, e124529. doi:&#xa0;10.1172/jci.insight.124529</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.124529</ArticleId><ArticleId IdType="pmc">PMC6777837</ArticleId><ArticleId IdType="pubmed">31343988</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G., Du W., Sang X., Tong Q., Wang Y., Chen G., et al. . (2022. a). RNA G-quadruplex in TMPRSS2 reduces SARS-CoV-2 infection. Nat. Commun. 13. doi:&#xa0;10.1038/s41467-022-29135-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29135-5</ArticleId><ArticleId IdType="pmc">PMC8931161</ArticleId><ArticleId IdType="pubmed">35301316</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G., Du W., Xu H., Sun Q., Tang D., Zou S., et al. . (2020). RNA G-quadruplex regulates microRNA-26a biogenesis and function. J. Hepatol. 73, 371&#x2013;382. doi:&#xa0;10.1016/j.jhep.2020.02.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.02.032</ArticleId><ArticleId IdType="pubmed">32165252</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G., Lee J. H., Parker Z. M., Acharya D., Chiang J. J., van Gent M., et al. . (2021). ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity. Nat. Microbiol. 6, 467&#x2013;478. doi:&#xa0;10.1038/s41564-021-00884-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00884-1</ArticleId><ArticleId IdType="pmc">PMC8103894</ArticleId><ArticleId IdType="pubmed">33727702</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J. W. Y., Su Q., Yeoh Y. K., Lui G. C., Ng S. S. S., et al. . (2022. b). Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut 71, 544&#x2013;552. doi:&#xa0;10.1136/gutjnl-2021-325989</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Wang H., Zhang H., Sui L., Li L., Xu W., et al. (2022. c)The global succinylation of SARS-CoV-2-infected host cells reveals drug targets. Proc. Natl. Acad. Sci. U.S.A. 119, e2123065119. doi:&#xa0;10.1073/pnas.2123065119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2123065119</ArticleId><ArticleId IdType="pmc">PMC9335334</ArticleId><ArticleId IdType="pubmed">35858407</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Zhang L., Joo D., Sun S. C. (2017). NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2. doi:&#xa0;10.1038/sigtrans.2017.23</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sigtrans.2017.23</ArticleId><ArticleId IdType="pmc">PMC5661633</ArticleId><ArticleId IdType="pubmed">29158945</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Zhang Y., Tian Y., Huang W., Tong N., Fu X. (2022). Integrative biology of extracellular vesicles in diabetes mellitus and diabetic complications. Theranostics 12, 1342&#x2013;1372. doi:&#xa0;10.7150/thno.65778</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.65778</ArticleId><ArticleId IdType="pmc">PMC8771544</ArticleId><ArticleId IdType="pubmed">35154494</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou Z., Rao Z. (2022). The life of SARS-CoV-2 inside cells: Replication-transcription complex assembly and function. Annu. Rev. Biochem. 91, 381&#x2013;401. doi:&#xa0;10.1146/annurev-biochem-052521-115653</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-052521-115653</ArticleId><ArticleId IdType="pubmed">35729072</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowery S. A., Sariol A., Perlman S. (2021). Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19. Cell Host Microbe 29, 1052&#x2013;1062. doi:&#xa0;10.1016/j.chom.2021.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8126603</ArticleId><ArticleId IdType="pubmed">34022154</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu D., Chatterjee S., Xiao K., Riedel I., Wang Y., Foo R., et al. . (2020). MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes. J. Mol. Cell Cardiol. 148, 46&#x2013;49. doi:&#xa0;10.1016/j.yjmcc.2020.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2020.08.017</ArticleId><ArticleId IdType="pmc">PMC7470794</ArticleId><ArticleId IdType="pubmed">32891636</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X., Pan J., Tao J., Guo D. (2011). SARS-CoV nucleocapsid protein antagonizes IFN-&#x3b2; response by targeting initial step of IFN-&#x3b2; induction pathway, and its C-terminal region is critical for the antagonism. Virus Genes 42, 37&#x2013;45. doi:&#xa0;10.1007/s11262-010-0544-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-010-0544-x</ArticleId><ArticleId IdType="pmc">PMC7088804</ArticleId><ArticleId IdType="pubmed">20976535</ArticleId></ArticleIdList></Reference><Reference><Citation>Luban J., Sattler R. A., M&#xfc;hlberger E., Graci J. D., Cao L., Weetall M., et al. . (2021). The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines. Virus Res. 292, 198246. doi:&#xa0;10.1016/j.virusres.2020.198246</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198246</ArticleId><ArticleId IdType="pmc">PMC7690341</ArticleId><ArticleId IdType="pubmed">33249060</ArticleId></ArticleIdList></Reference><Reference><Citation>Luningschror P., Werner G., Stroobants S., Kakuta S., Dombert B., Sinske D., et al. . (2020). The FTLD risk factor TMEM106B regulates the transport of lysosomes at the axon initial segment of motoneurons. Cell Rep. 30, 3506&#x2013;3519. e3506. doi:&#xa0;10.1016/j.celrep.2020.02.060</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.02.060</ArticleId><ArticleId IdType="pubmed">32160553</ArticleId></ArticleIdList></Reference><Reference><Citation>Mah&#xe9; D., Bourgeau S., da Silva J., Schlederer J., Satie A. P., Kuassivi N., et al. . (2023). SARS-CoV-2 replicates in the human testis with slow kinetics and has no major deleterious effects ex vivo. J. Virol. 97, e0110423. doi:&#xa0;10.1128/jvi.01104-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01104-23</ArticleId><ArticleId IdType="pmc">PMC10653996</ArticleId><ArticleId IdType="pubmed">37830818</ArticleId></ArticleIdList></Reference><Reference><Citation>Majidpoor J., Mortezaee K. (2022). Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications. BioMed. Pharmacother. 145, 112419. doi:&#xa0;10.1016/j.biopha.2021.112419</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.112419</ArticleId><ArticleId IdType="pmc">PMC8585600</ArticleId><ArticleId IdType="pubmed">34781146</ArticleId></ArticleIdList></Reference><Reference><Citation>Malone B., Urakova N., Snijder E. J., Campbell E. A. (2022). Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design. Nat. Rev. Mol. Cell Biol. 23, 21&#x2013;39. doi:&#xa0;10.1038/s41580-021-00432-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00432-z</ArticleId><ArticleId IdType="pmc">PMC8613731</ArticleId><ArticleId IdType="pubmed">34824452</ArticleId></ArticleIdList></Reference><Reference><Citation>Mani S., Kaur A., Jakhar K., Kumari G., Sonar S., Kumar A., et al. . (2023). Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections. Int. J. Biol. Macromol 245, 125444. doi:&#xa0;10.1016/j.ijbiomac.2023.125444</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2023.125444</ArticleId><ArticleId IdType="pmc">PMC10293653</ArticleId><ArticleId IdType="pubmed">37385308</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann M. M., Hsieh M. K., Tang J. D., Hart W. S., Lazzara M. J., Klauda J. B., et al. . (2023). Understanding how transmembrane domains regulate interactions between human BST-2 and the SARS-CoV-2 accessory protein ORF7a. Biochim. Biophys. Acta Biomembr 1865, 184174. doi:&#xa0;10.1016/j.bbamem.2023.184174</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2023.184174</ArticleId><ArticleId IdType="pmc">PMC10197439</ArticleId><ArticleId IdType="pubmed">37211321</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao K., Tan Q., Ma Y., Wang S., Zhong H., Liao Y., et al. . (2021). Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery. Cell Death Dis. 12, 541. doi:&#xa0;10.1038/s41419-021-03816-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03816-3</ArticleId><ArticleId IdType="pmc">PMC8146187</ArticleId><ArticleId IdType="pubmed">34035220</ArticleId></ArticleIdList></Reference><Reference><Citation>Maranini B., Ciancio G., Ferracin M., Cultrera R., Negrini M., Sabbioni S., et al. . (2022). microRNAs and inflammatory immune response in SARS-CoV-2 infection: A narrative review. Life (Basel) 12. doi:&#xa0;10.3390/life12020288</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020288</ArticleId><ArticleId IdType="pmc">PMC8879390</ArticleId><ArticleId IdType="pubmed">35207576</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariappan V., S R, R., Balakrishna A. (2020). Angiotensin-converting enzyme 2: A protective factor in regulating disease virulence of SARS-COV-2. IUBMB Life 72, 2533&#x2013;2545. doi:&#xa0;10.1002/iub.2391</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.2391</ArticleId><ArticleId IdType="pubmed">33031602</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-M&#xe1;rmol R., Giordano-Santini R., Kaulich E., Cho A. N., Przybyla M., Riyadh M. A., et al. . (2023). SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity. Sci. Adv. 9, eadg2248. doi:&#xa0;10.1126/sciadv.adg2248</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.adg2248</ArticleId><ArticleId IdType="pmc">PMC10246911</ArticleId><ArticleId IdType="pubmed">37285437</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Sanz J., Jimenez D., Martinez-Campelo L., Cruz R., Vizcarra P., Sanchez-Conde M., et al. . (2021). Role of ACE2 genetic polymorphisms in susceptibility to SARS-CoV-2 among highly exposed but non infected healthcare workers. Emerg. Microbes Infect. 10, 493&#x2013;496. doi:&#xa0;10.1080/22221751.2021.1902755</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1902755</ArticleId><ArticleId IdType="pmc">PMC7993370</ArticleId><ArticleId IdType="pubmed">33704002</ArticleId></ArticleIdList></Reference><Reference><Citation>Matarese A., Gambardella J., Sardu C., Santulli G. (2020). miR-98 regulates TMPRSS2 expression in human endothelial cells: Key implications for COVID-19. Biomedicines 8. doi:&#xa0;10.3390/biomedicines8110462</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8110462</ArticleId><ArticleId IdType="pmc">PMC7693865</ArticleId><ArticleId IdType="pubmed">33143053</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei K., Guo W. (2018). The exocyst complex. Curr. Biol. 28, R922&#x2013;R925. doi:&#xa0;10.1016/j.cub.2018.06.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2018.06.042</ArticleId><ArticleId IdType="pubmed">30205058</ArticleId></ArticleIdList></Reference><Reference><Citation>Melenotte C., Silvin A., Goubet A. G., Lahmar I., Dubuisson A., Zumla A., et al. . (2020). Immune responses during COVID-19 infection. Oncoimmunology 9, 1807836. doi:&#xa0;10.1080/2162402X.2020.1807836</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/2162402X.2020.1807836</ArticleId><ArticleId IdType="pmc">PMC7480812</ArticleId><ArticleId IdType="pubmed">32939324</ArticleId></ArticleIdList></Reference><Reference><Citation>Melms J. C., Biermann J., Huang H., Wang Y., Nair A., Tagore S., et al. . (2021). A molecular single-cell lung atlas of lethal COVID-19. Nature. 595 (7865), 114&#x2013;119. doi:&#xa0;10.1038/s41586-021-03569-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03569-1</ArticleId><ArticleId IdType="pmc">PMC8814825</ArticleId><ArticleId IdType="pubmed">33915568</ArticleId></ArticleIdList></Reference><Reference><Citation>Merello M., Bhatia K. P., Obeso J. A. (2021). SARS-CoV-2 and the risk of Parkinson&#x2019;s disease: facts and fantasy. Lancet Neurol. 20, 94&#x2013;95. doi:&#xa0;10.1016/S1474-4422(20)30442-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30442-7</ArticleId><ArticleId IdType="pmc">PMC7834123</ArticleId><ArticleId IdType="pubmed">33253627</ArticleId></ArticleIdList></Reference><Reference><Citation>Meringer H., Mehandru S. (2022). Gastrointestinal post-acute COVID-19 syndrome. Nat. Rev. Gastroenterol. Hepatol. 19, 345&#x2013;346. doi:&#xa0;10.1038/s41575-022-00611-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00611-z</ArticleId><ArticleId IdType="pmc">PMC8981882</ArticleId><ArticleId IdType="pubmed">35383321</ArticleId></ArticleIdList></Reference><Reference><Citation>Minkoff J. M., tenOever B. (2023). Innate immune evasion strategies of SARS-CoV-2. Nat. Rev. Microbiol. 21, 178&#x2013;194. doi:&#xa0;10.1038/s41579-022-00839-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00839-1</ArticleId><ArticleId IdType="pmc">PMC9838430</ArticleId><ArticleId IdType="pubmed">36631691</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra R., Banerjea A. C. (2021). SARS-CoV-2 spike targets USP33-IRF9 axis via exosomal miR-148a to activate human microglia. Front. Immunol. 12. doi:&#xa0;10.3389/fimmu.2021.656700</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.656700</ArticleId><ArticleId IdType="pmc">PMC8079643</ArticleId><ArticleId IdType="pubmed">33936086</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M., Iwasaki A. (2022). The neurobiology of long COVID. Neuron 110, 3484&#x2013;3496. doi:&#xa0;10.1016/j.neuron.2022.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Monk P. D., Marsden R. J., Tear V. J., Brookes J., Batten T. N., Mankowski M., et al. . (2021). Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Respir. Med. 9, 196&#x2013;206. doi:&#xa0;10.1016/S2213-2600(20)30511-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30511-7</ArticleId><ArticleId IdType="pmc">PMC7836724</ArticleId><ArticleId IdType="pubmed">33189161</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L., Ben Nasr M., D&#x2019;Addio F., Loretelli C., Rossi A., Pastore I., et al. . (2021). Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat. Metab. 3, 774&#x2013;785. doi:&#xa0;10.1038/s42255-021-00407-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteil V., Kwon H., Prado P., Hagelkr&#xfc;ys A., Wimmer R. A., Stahl M., et al. . (2020). Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181, 905&#x2013;913.e907. doi:&#xa0;10.1016/j.cell.2020.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7181998</ArticleId><ArticleId IdType="pubmed">32333836</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu J., Fang Y., Yang Q., Shu T., Wang A., Huang M., et al. . (2020). SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2. Cell Discovery 6. doi:&#xa0;10.1038/s41421-020-00208-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-00208-3</ArticleId><ArticleId IdType="pmc">PMC7490572</ArticleId><ArticleId IdType="pubmed">32953130</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller J. A., Gro&#xdf; R., Conzelmann C., Kr&#xfc;ger J., Merle U., Steinhart J., et al. . (2021). SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat. Metab. 3, 149&#x2013;165. doi:&#xa0;10.1038/s42255-021-00347-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00347-1</ArticleId><ArticleId IdType="pubmed">33536639</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami N., Hayden R., Hills T., Al-Samkari H., Casey J., Del Sorbo L., et al. . (2023). Therapeutic advances in COVID-19. Nat. Rev. Nephrol. 19, 38&#x2013;52. doi:&#xa0;10.1038/s41581-022-00642-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-022-00642-4</ArticleId><ArticleId IdType="pmc">PMC9574806</ArticleId><ArticleId IdType="pubmed">36253508</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray R. S., Brown B., Brian D., Cabirac G. F. (1992). Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann. Neurol. 31, 525&#x2013;533. doi:&#xa0;10.1002/ana.410310511</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410310511</ArticleId><ArticleId IdType="pmc">PMC7159714</ArticleId><ArticleId IdType="pubmed">1596089</ArticleId></ArticleIdList></Reference><Reference><Citation>Nainu F., Shiratsuchi A., Nakanishi Y. (2017). Induction of apoptosis and subsequent phagocytosis of virus-infected cells as an antiviral mechanism. Front. Immunol. 8. doi:&#xa0;10.3389/fimmu.2017.01220</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01220</ArticleId><ArticleId IdType="pmc">PMC5624992</ArticleId><ArticleId IdType="pubmed">29033939</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair S., Nova-Lamperti E., Labarca G., Kulasinghe A., Short K. R., Carri&#xf3;n F., et al. . (2023). Genomic communication via circulating extracellular vesicles and long-term health consequences of COVID-19. J. Transl. Med. 21, 709. doi:&#xa0;10.1186/s12967-023-04552-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04552-2</ArticleId><ArticleId IdType="pmc">PMC10563316</ArticleId><ArticleId IdType="pubmed">37817137</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura Y., Katano H., Nakajima N., Sato Y., Suzuki T., Sekizuka T., et al. . (2021). SARS-CoV-2 is localized in cardiomyocytes: a postmortem biopsy case. Int. J. Infect. Dis. 111, 43&#x2013;46. doi:&#xa0;10.1016/j.ijid.2021.08.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.08.015</ArticleId><ArticleId IdType="pmc">PMC8351278</ArticleId><ArticleId IdType="pubmed">34384897</ArticleId></ArticleIdList></Reference><Reference><Citation>Namkoong H., Edahiro R., Takano T., Nishihara H., Shirai Y., Sonehara K., et al. . (2022). DOCK2 is involved in the host genetics and biology of severe COVID-19. Nature 609, 754&#x2013;760. doi:&#xa0;10.1038/s41586-022-05163-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05163-5</ArticleId><ArticleId IdType="pmc">PMC9492544</ArticleId><ArticleId IdType="pubmed">35940203</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo A. D., Schneeweiss-Gleixner M., Bakail M., Dixon E. D., Lax S. F., Trauner M. (2021). Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 41, 20&#x2013;32. doi:&#xa0;10.1111/liv.14730</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.14730</ArticleId><ArticleId IdType="pmc">PMC7753756</ArticleId><ArticleId IdType="pubmed">33190346</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishitsuji H., Iwahori S., Ohmori M., Shimotohno K., Murata T. (2022). Ubiquitination of SARS-CoV-2 NSP6 and ORF7a facilitates NF-&#x3ba;B activation. mBio 13, e0097122. doi:&#xa0;10.1128/mbio.00971-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00971-22</ArticleId><ArticleId IdType="pmc">PMC9426613</ArticleId><ArticleId IdType="pubmed">35856559</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolen L. T., Mukerji S. S., Mejia N. I. (2022). Post-acute neurological consequences of COVID-19: an unequal burden. Nat. Med. 28 (1), 20&#x2013;23. doi:&#xa0;10.1038/s41591-021-01647-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01647-5</ArticleId><ArticleId IdType="pubmed">35039657</ArticleId></ArticleIdList></Reference><Reference><Citation>Okugawa S., Ikeda M., Kashiwabara K., Moritoyo T., Kohsaka T., Shimizu T., et al. . (2023). Antiviral effect and safety of nafamostat mesilate in patients with mild early-onset COVID-19: An exploratory multicentre randomized controlled clinical trial. Int. J. Antimicrob. Agents 62, 106922. doi:&#xa0;10.1016/j.ijantimicag.2023.106922</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2023.106922</ArticleId><ArticleId IdType="pubmed">37429450</ArticleId></ArticleIdList></Reference><Reference><Citation>Omer D., Pleniceanu O., Gnatek Y., Namestnikov M., Cohen-Zontag O., Goldberg S., et al. . (2021). Human kidney spheroids and monolayers provide insights into SARS-CoV-2 renal interactions. J. Am. Soc. Nephrol. 32, 2242&#x2013;2254. doi:&#xa0;10.1681/ASN.2020111546</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020111546</ArticleId><ArticleId IdType="pmc">PMC8729846</ArticleId><ArticleId IdType="pubmed">34112705</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortatatli M., Fatsa T., Mulazimoglu D. D., Oren S., Artuk C., Hosbul T., et al. . (2023). Role of ACE2 and the proteases as TMPRSS2 and Furin on SARS-CoV-2 pathogenesis and COVID-19 severity. Arch. Med. Res. 54, 223&#x2013;230. doi:&#xa0;10.1016/j.arcmed.2023.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2023.02.002</ArticleId><ArticleId IdType="pmc">PMC9925418</ArticleId><ArticleId IdType="pubmed">36914430</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann P. N., Schaal H. (2023). Human brain organoids to explore SARS-CoV-2-induced effects on the central nervous system. Rev. Med. Virol. 33, e2430. doi:&#xa0;10.1002/rmv.2430</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2430</ArticleId><ArticleId IdType="pubmed">36790825</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou T., Mou H., Zhang L., Ojha A., Choe H., Farzan M. (2021). Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2. PloS Pathog. 17, e1009212. doi:&#xa0;10.1371/journal.ppat.1009212</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009212</ArticleId><ArticleId IdType="pmc">PMC7845965</ArticleId><ArticleId IdType="pubmed">33465165</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudit G. Y., Wang K., Viveiros A., Kellner M. J., Penninger J. M. (2023). Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic. Cell 186, 906&#x2013;922. doi:&#xa0;10.1016/j.cell.2023.01.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.01.039</ArticleId><ArticleId IdType="pmc">PMC9892333</ArticleId><ArticleId IdType="pubmed">36787743</ArticleId></ArticleIdList></Reference><Reference><Citation>Palao M., Fern&#xe1;ndez-D&#xed;az E., Gracia-Gil J., Romero-S&#xe1;nchez C. M., D&#xed;az-Maroto I., Segura T. (2020). Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat. Disord. 45, 102377. doi:&#xa0;10.1016/j.msard.2020.102377</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2020.102377</ArticleId><ArticleId IdType="pmc">PMC7340057</ArticleId><ArticleId IdType="pubmed">32698095</ArticleId></ArticleIdList></Reference><Reference><Citation>Paradis P., Dali-Youcef N., Paradis F. W., Thibault G., Nemer M. (2000). Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc. Natl. Acad. Sci. U.S.A. 97, 931&#x2013;936. doi:&#xa0;10.1073/pnas.97.2.931</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.2.931</ArticleId><ArticleId IdType="pmc">PMC15433</ArticleId><ArticleId IdType="pubmed">10639182</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawlica P., Yario T. A., White S., Wang J., Moss W. N., Hui P., et al. . (2021). SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes. Proc. Natl. Acad. Sci. U.S.A. 118. doi:&#xa0;10.1073/pnas.2116668118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2116668118</ArticleId><ArticleId IdType="pmc">PMC8719879</ArticleId><ArticleId IdType="pubmed">34903581</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M. J., Deeks S. G., Mustapic M., Kapogiannis D., Henrich T. J., Lu S., et al. . (2022). SARS-CoV-2 and mitochondrial proteins in neural-derived exosomes of COVID-19. Ann. Neurol. 91, 772&#x2013;781. doi:&#xa0;10.1002/ana.26350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26350</ArticleId><ArticleId IdType="pmc">PMC9082480</ArticleId><ArticleId IdType="pubmed">35285072</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennisi M., Lanza G., Falzone L., Fisicaro F., Ferri R., Bella R. (2020). SARS-CoV-2 and the nervous system: From clinical features to molecular mechanisms. Int. J. Mol. Sci. 21. doi:&#xa0;10.3390/ijms21155475</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21155475</ArticleId><ArticleId IdType="pmc">PMC7432482</ArticleId><ArticleId IdType="pubmed">32751841</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D. R., Wilson D. B., Howe A., Munier C. M. L., Patel S. K., et al. . (2022). Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210&#x2013;216. doi:&#xa0;10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponde N. O., Shoger K. E., Khatun M. S., Sarkar M. K., Dey I., Taylor T. C., et al. . (2023). SARS-CoV-2 ORF8 mediates signals in macrophages and monocytes through MyD88 independently of the IL-17 receptor. J. Immunol. 211, 252&#x2013;260. doi:&#xa0;10.4049/jimmunol.2300110</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2300110</ArticleId><ArticleId IdType="pmc">PMC10330444</ArticleId><ArticleId IdType="pubmed">37265402</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V. O., Carerj M. L., Wieters I., Fahim M., Arendt C., Hoffmann J., et al. . (2020). Outcomes of cardiovascular margnetic esonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5, 1265&#x2013;1273. doi:&#xa0;10.1001/jamacardio.2020.3557</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi J., Zhou Y., Hua J., Zhang L., Bian J., Liu B., et al. . (2021). The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to SARS-CoV-2 infection. Int. J. Environ. Res. Public Health 18. doi:&#xa0;10.3390/ijerph18010284</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18010284</ArticleId><ArticleId IdType="pmc">PMC7794913</ArticleId><ArticleId IdType="pubmed">33401657</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin G., Zhao C., Yang J., Wang Z., Ren J., Qu X. (2022). Unlocking G-Quadruplexes as targets and tools against COVID-19. Chin. J. Chem. 30, 10.1002/cjoc.202200486. doi:&#xa0;10.1002/cjoc.202200486</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cjoc.202200486</ArticleId><ArticleId IdType="pmc">PMC9874442</ArticleId><ArticleId IdType="pubmed">36711116</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu L., Wang T., Tang Q., Li G., Wu P., Chen K. (2018). Long non-coding RNAs: Regulators of viral infection and the interferon antiviral response. Front. Microbiol. 9. doi:&#xa0;10.3389/fmicb.2018.01621</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.01621</ArticleId><ArticleId IdType="pmc">PMC6060254</ArticleId><ArticleId IdType="pubmed">30072977</ArticleId></ArticleIdList></Reference><Reference><Citation>Raab-Traub N., Dittmer D. P. (2017). Viral effects on the content and function of extracellular vesicles. Nat. Rev. Microbiol. 15, 559&#x2013;572. doi:&#xa0;10.1038/nrmicro.2017.60</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2017.60</ArticleId><ArticleId IdType="pmc">PMC5555775</ArticleId><ArticleId IdType="pubmed">28649136</ArticleId></ArticleIdList></Reference><Reference><Citation>Raha A. A., Chakraborty S., Henderson J., Mukaetova-Ladinska E., Zaman S., Trowsdale J., et al. . (2020). Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology. Biosci. Rep. 40. doi:&#xa0;10.1042/BSR20203092</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20203092</ArticleId><ArticleId IdType="pmc">PMC7693198</ArticleId><ArticleId IdType="pubmed">33205807</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajarshi K., Khan R., Singh M. K., Ranjan T., Ray S., Ray S. (2021). Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19. Gene 768, 145313. doi:&#xa0;10.1016/j.gene.2020.145313</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2020.145313</ArticleId><ArticleId IdType="pmc">PMC7673215</ArticleId><ArticleId IdType="pubmed">33220345</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S., Tong M. S., Borchers J., Zareba K. M., Obarski T. P., Simonetti O. P., et al. . (2021). Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 6, 116&#x2013;118. doi:&#xa0;10.1001/jamacardio.2020.4916</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.4916</ArticleId><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D. A., L&#xfc;scher T. F., Neubauer S. (2022). Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 43, 1157&#x2013;1172. doi:&#xa0;10.1093/eurheartj/ehac031</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashid F., Xie Z., Suleman M., Shah A., Khan S., Luo S. (2022). Roles and functions of SARS-CoV-2 proteins in host immune evasion. Front. Immunol. 13. doi:&#xa0;10.3389/fimmu.2022.940756</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.940756</ArticleId><ArticleId IdType="pmc">PMC9394213</ArticleId><ArticleId IdType="pubmed">36003396</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravi V., Saxena S., Panda P. S. (2022). Basic virology of SARS-coV 2. Indian J. Med. Microbiol. 40, 182&#x2013;186. doi:&#xa0;10.1016/j.ijmmb.2022.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmmb.2022.02.005</ArticleId><ArticleId IdType="pmc">PMC8919811</ArticleId><ArticleId IdType="pubmed">35300895</ArticleId></ArticleIdList></Reference><Reference><Citation>Redin C., Thorball C. W., Fellay J. (2022). Host genomics of SARS-CoV-2 infection. Eur. J. Hum. Genet. 30, 908&#x2013;914. doi:&#xa0;10.1038/s41431-022-01136-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-022-01136-4</ArticleId><ArticleId IdType="pmc">PMC9244159</ArticleId><ArticleId IdType="pubmed">35768520</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiterer M., Rajan M., G&#xf3;mez-Banoy N., Lau J. D., Gomez-Escobar L. G., Ma L., et al. . (2021). Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab. 33, 2174&#x2013;2188.e2175. doi:&#xa0;10.1016/j.cmet.2021.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8443335</ArticleId><ArticleId IdType="pubmed">34599884</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro M. R., Calado A. M., Alves &#xc2;., Pereira R., Sousa M., S&#xe1; R. (2023). Spatial distribution of SARS-CoV-2 receptors and proteases in testicular cells. J. Histochem Cytochem 71, 169&#x2013;197. doi:&#xa0;10.1369/00221554231168916</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/00221554231168916</ArticleId><ArticleId IdType="pmc">PMC10083717</ArticleId><ArticleId IdType="pubmed">37026452</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez Hermosa J. L., Vargas Centanaro G., Gonz&#xe1;lez Castro M. E., Miravitlles M., L&#xe1;zaro-Asegurado L., Jim&#xe9;nez-Rodr&#xed;guez B. M., et al. . (2023). Severe COVID-19 illness and &#x3b1;1-antitrypsin deficiency: COVID-AATD study. Biomedicines 11. doi:&#xa0;10.3390/biomedicines11020516</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11020516</ArticleId><ArticleId IdType="pmc">PMC9953718</ArticleId><ArticleId IdType="pubmed">36831051</ArticleId></ArticleIdList></Reference><Reference><Citation>Roganovi&#x107; J. R. (2021). microRNA-146a and -155, upregulated by periodontitis and type 2 diabetes in oral fluids, are predicted to regulate SARS-CoV-2 oral receptor genes. J. Periodontol 92, 35&#x2013;43. doi:&#xa0;10.1002/jper.20-0623</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jper.20-0623</ArticleId><ArticleId IdType="pubmed">33336412</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy-Vallejo E., Fern&#xe1;ndez De C&#xf3;rdoba-O&#xf1;ate S., Delgado-Wicke P., Triguero-Mart&#xed;nez A., Montes N., Carracedo-Rodr&#xed;guez R., et al. . (2023). Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis. Front. Med. (Lausanne) 10. doi:&#xa0;10.3389/fmed.2023.1215246</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1215246</ArticleId><ArticleId IdType="pmc">PMC10557488</ArticleId><ArticleId IdType="pubmed">37809329</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacar Demirci M. D., Adan A. (2020). Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection. PeerJ 8, e9369. doi:&#xa0;10.7717/peerj.9369</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.9369</ArticleId><ArticleId IdType="pmc">PMC7278893</ArticleId><ArticleId IdType="pubmed">32547891</ArticleId></ArticleIdList></Reference><Reference><Citation>Saengsiwaritt W., Jittikoon J., Chaikledkaew U., Udomsinprasert W. (2022). Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis. Rev. Med. Virol. 32, e2323. doi:&#xa0;10.1002/rmv.2323</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2323</ArticleId><ArticleId IdType="pubmed">34997794</ArticleId></ArticleIdList></Reference><Reference><Citation>Samelson A. J., Tran Q. D., Robinot R., Carrau L., Rezelj V. V., Kain A. M., et al. . (2022). BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2. Nat. Cell Biol. 24, 24&#x2013;34. doi:&#xa0;10.1038/s41556-021-00821-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-021-00821-8</ArticleId><ArticleId IdType="pmc">PMC8820466</ArticleId><ArticleId IdType="pubmed">35027731</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos R. A., Castro C. H., Gava E., Pinheiro S. V., Almeida A. P., Paula R. D., et al. . (2006). Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor MAS knockout mice. Hypertension 47, 996&#x2013;1002. doi:&#xa0;10.1161/01.HYP.0000215289.51180.5c</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000215289.51180.5c</ArticleId><ArticleId IdType="pubmed">16567589</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarino A., Boelaert J. R., Cassone A., Majori G., Cauda R. (2003). Effects of chloroquine on viral infections: an old drug against today&#x2019;s diseases? Lancet Infect. Dis. 3, 722&#x2013;727. doi:&#xa0;10.1016/s1473-3099(03)00806-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(03)00806-5</ArticleId><ArticleId IdType="pmc">PMC7128816</ArticleId><ArticleId IdType="pubmed">14592603</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer K. M., Mascheroni L., Carnell G. W., Wunderlich L. C. S., Makarchuk S., Brockhoff M., et al. . (2022). SARS-CoV-2 nucleocapsid protein adheres to replication organelles before viral assembly at the Golgi/ERGIC and lysosome-mediated egress. Sci. Adv. 8, eabl4895. doi:&#xa0;10.1126/sciadv.abl4895</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abl4895</ArticleId><ArticleId IdType="pmc">PMC10954198</ArticleId><ArticleId IdType="pubmed">34995113</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt N., Lareau C. A., Keshishian H., Ganskih S., Schneider C., Hennig T., et al. . (2021). The SARS-CoV-2 RNA-protein interactome in infected human cells. Nat. Microbiol. 6, 339&#x2013;353. doi:&#xa0;10.1038/s41564-020-00846-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-00846-z</ArticleId><ArticleId IdType="pmc">PMC7906908</ArticleId><ArticleId IdType="pubmed">33349665</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt C. A., Tchkonia T., Niedernhofer L. J., Robbins P. D., Kirkland J. L., Lee S. (2023). COVID-19 and cellular senescence. Nat. Rev. Immunol. 23, 251&#x2013;263. doi:&#xa0;10.1038/s41577-022-00785-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00785-2</ArticleId><ArticleId IdType="pmc">PMC9533263</ArticleId><ArticleId IdType="pubmed">36198912</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider W. M., Luna J. M., Hoffmann H. H., S&#xe1;nchez-Rivera F. J., Leal A. A., Ashbrook A. W., et al. . (2021). Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks. Cell 184, 120&#x2013;132.e114. doi:&#xa0;10.1016/j.cell.2020.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.006</ArticleId><ArticleId IdType="pmc">PMC7796900</ArticleId><ArticleId IdType="pubmed">33382968</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert K., Karousis E. D., Jomaa A., Scaiola A., Echeverria B., Gurzeler L. A., et al. . (2020). SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation. Nat. Struct. Mol. Biol. 27, 959&#x2013;966. doi:&#xa0;10.1038/s41594-020-0511-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-0511-8</ArticleId><ArticleId IdType="pubmed">32908316</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze J. L., Aschenbrenner A. C. (2021). COVID-19 and the human innate immune system. Cell 184, 1671&#x2013;1692. doi:&#xa0;10.1016/j.cell.2021.02.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.029</ArticleId><ArticleId IdType="pmc">PMC7885626</ArticleId><ArticleId IdType="pubmed">33743212</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciaudone A., Corkrey H., Humphries F., Koupenova M. (2023). Platelets and SARS-CoV-2 during COVID-19: Immunity, thrombosis, and beyond. Circ. Res. 132, 1272&#x2013;1289. doi:&#xa0;10.1161/CIRCRESAHA.122.321930</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.321930</ArticleId><ArticleId IdType="pmc">PMC10171305</ArticleId><ArticleId IdType="pubmed">37167360</ArticleId></ArticleIdList></Reference><Reference><Citation>Senapati S., Kumar S., Singh A., Banerjee P., Bhagavatula S. (2020). TMPRSS2Assessment of risk conferred by coding and regulatory variations of and in susceptibility to SARS-CoV-2 infection in human. J. Genet. 99. doi:&#xa0;10.1007/s12041-020-01217-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12041-020-01217-7</ArticleId><ArticleId IdType="pmc">PMC7280172</ArticleId><ArticleId IdType="pubmed">32661206</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpeloni J. M., Lima Neto Q. A., Lucio L. C., Ram&#xe3;o A., Carvalho de Oliveira J., Gradia D. F., et al. . (2021). Genome interaction of the virus and the host genes and non-coding RNAs in SARS-CoV-2 infection. Immunobiology 226, 152130. doi:&#xa0;10.1016/j.imbio.2021.152130</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2021.152130</ArticleId><ArticleId IdType="pmc">PMC8378551</ArticleId><ArticleId IdType="pubmed">34425415</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah P. L., Orton C. M., Grinsztejn B., Donaldson G. C., Crabtree Ram&#xed;rez B., Tonkin J., et al. . (2023). Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care. Lancet Respir. Med. 11, 415&#x2013;424. doi:&#xa0;10.1016/S2213-2600(22)00412-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00412-X</ArticleId><ArticleId IdType="pmc">PMC9891737</ArticleId><ArticleId IdType="pubmed">36528039</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapira T., Monreal I. A., Dion S. P., Buchholz D. W., Imbiakha B., Olmstead A. D., et al. . (2022). A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic. Nature 605, 340&#x2013;348. doi:&#xa0;10.1038/s41586-022-04661-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04661-w</ArticleId><ArticleId IdType="pmc">PMC9095466</ArticleId><ArticleId IdType="pubmed">35344983</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma I., Kumari P., Sharma A., Saha S. C. (2021). SARS-CoV-2 and the reproductive system: known and the unknown Middle East Fertil Soc. J. 26, 1. doi:&#xa0;10.1186/s43043-020-00046-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43043-020-00046-z</ArticleId><ArticleId IdType="pmc">PMC7789900</ArticleId><ArticleId IdType="pubmed">33437145</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelton J. F., Shastri A. J., Fletez-Brant K., Me C. T., Aslibekyan S., Auton A. (2022). The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. Nat. Genet. 54 (2), 121&#x2013;124. doi:&#xa0;10.1038/s41588-021-00986-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00986-w</ArticleId><ArticleId IdType="pubmed">35039640</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Q., Xiao X., Aierken A., Yue W., Wu X., Liao M., et al. . (2020). The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection. J. Cell Mol. Med. 24, 9472&#x2013;9477. doi:&#xa0;10.1111/jcmm.15541</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15541</ArticleId><ArticleId IdType="pmc">PMC7361928</ArticleId><ArticleId IdType="pubmed">32594644</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif Z. A., Gomez C. R., Connors T. J., Henrich T. J., Reeves W. B. (2023). Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). Elife 22, e86002. doi:&#xa0;10.7554/eLife.86002</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Du T., Wang J., Tang C., Lei M., Yu W., et al. . (2023). Aryl hydrocarbon receptor is a proviral host factor and a candidate pan-SARS-CoV-2 therapeutic target. Sci. Adv. 9, eadf0211. doi:&#xa0;10.1126/sciadv.adf0211</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.adf0211</ArticleId><ArticleId IdType="pmc">PMC10413656</ArticleId><ArticleId IdType="pubmed">37256962</ArticleId></ArticleIdList></Reference><Reference><Citation>Singal C. M. S., Jaiswal P., Seth P. (2020). SARS-CoV-2, more than a respiratory virus: Its potential role in neuropathogenesis. ACS Chem. Neurosci. 11, 1887&#x2013;1899. doi:&#xa0;10.1021/acschemneuro.0c00251</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00251</ArticleId><ArticleId IdType="pubmed">32491829</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K. K., Chaubey G., Chen J. Y., Suravajhala P. (2020). Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am. J. Physiol. Cell Physiol. 319, C258&#x2013;c267. doi:&#xa0;10.1152/ajpcell.00224.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00224.2020</ArticleId><ArticleId IdType="pmc">PMC7381712</ArticleId><ArticleId IdType="pubmed">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Snijder E. J., Limpens R., de Wilde A. H., de Jong A. W. M., Zevenhoven-Dobbe J. C., Maier H. J., et al. . (2020). A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis. PloS Biol. 18, e3000715. doi:&#xa0;10.1371/journal.pbio.3000715</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000715</ArticleId><ArticleId IdType="pmc">PMC7302735</ArticleId><ArticleId IdType="pubmed">32511245</ArticleId></ArticleIdList></Reference><Reference><Citation>Stafie C. S., Solomon S. M., Sufaru I. G., Manaila M., Stafie I. I., Melinte G., et al. . (2022). Pathogenic connections in post-COVID conditions: What do we know in the large unknown? A narrative review. Viruses 14. doi:&#xa0;10.3390/v14081686</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081686</ArticleId><ArticleId IdType="pmc">PMC9413998</ArticleId><ArticleId IdType="pubmed">36016309</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C., Richter S., Berger I., Barovic M., Schmid J., Schubert U., et al. . (2021). Viral infiltration of pancreatic islets in patients with COVID-19. Nat. Commun. 12. doi:&#xa0;10.1038/s41467-021-23886-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23886-3</ArticleId><ArticleId IdType="pmc">PMC8192507</ArticleId><ArticleId IdType="pubmed">34112801</ArticleId></ArticleIdList></Reference><Reference><Citation>Stukalov A., Girault V., Grass V., Karayel O., Bergant V., Urban C., et al. . (2021). Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature 594, 246&#x2013;252. doi:&#xa0;10.1038/s41586-021-03493-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03493-4</ArticleId><ArticleId IdType="pubmed">33845483</ArticleId></ArticleIdList></Reference><Reference><Citation>Summa K. C., Hanauer S. B. (2023). COVID-19 and inflammatory bowel disease. Gastroenterol. Clin. North Am. 52, 103&#x2013;113. doi:&#xa0;10.1016/j.gtc.2022.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gtc.2022.10.005</ArticleId><ArticleId IdType="pmc">PMC9618438</ArticleId><ArticleId IdType="pubmed">36813419</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Li P., Ju X., Rao J., Huang W., Ren L., et al. . (2021. b). In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs. Cell 184, 1865&#x2013;1883.e1820. doi:&#xa0;10.1016/j.cell.2021.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.008</ArticleId><ArticleId IdType="pmc">PMC7871767</ArticleId><ArticleId IdType="pubmed">33636127</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B., Tang N., Peluso M. J., Iyer N. S., Torres L., Donatelli J. L., et al. . (2021. a). Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations. Cells 10. doi:&#xa0;10.3390/cells10020386</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020386</ArticleId><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak W., Huang N., Becavin C., Berg M., Queen R., Litvinukova M., et al. . (2020). SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 26, 681&#x2013;687. doi:&#xa0;10.1038/s41591-020-0868-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryamohan K., Diwanji D., Stawiski E. W., Gupta R., Miersch S., Liu J., et al. . (2021). Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2. Commun. Biol. 4, 475. doi:&#xa0;10.1038/s42003-021-02030-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02030-3</ArticleId><ArticleId IdType="pmc">PMC8041869</ArticleId><ArticleId IdType="pubmed">33846513</ArticleId></ArticleIdList></Reference><Reference><Citation>Szlachcic W. J., Dabrowska A., Milewska A., Ziojla N., Blaszczyk K., Barreto-Duran E., et al. . (2022). SARS-CoV-2 infects an in vitro model of the human developing pancreas through endocytosis. iScience 25, 104594. doi:&#xa0;10.1016/j.isci.2022.104594</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104594</ArticleId><ArticleId IdType="pmc">PMC9212970</ArticleId><ArticleId IdType="pubmed">35756892</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajbakhsh A., Gheibi Hayat S. M., Taghizadeh H., Akbari A., Inabadi M., Savardashtaki A., et al. . (2021). COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev. Anti Infect. Ther. 19, 345&#x2013;357. doi:&#xa0;10.1080/14787210.2020.1822737</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2020.1822737</ArticleId><ArticleId IdType="pubmed">32921216</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda M. (2022). Proteolytic activation of SARS-CoV-2 spike protein. Microbiol. Immunol. 66, 15&#x2013;23. doi:&#xa0;10.1111/1348-0421.12945</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1348-0421.12945</ArticleId><ArticleId IdType="pmc">PMC8652499</ArticleId><ArticleId IdType="pubmed">34561887</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao K., Tzou P. L., Nouhin J., Bonilla H., Jagannathan P., Shafer R. W. (2021). SARS-CoV-2 antiviral therapy. Clin. Microbiol. Rev. 34, e0010921. doi:&#xa0;10.1128/CMR.00109-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00109-21</ArticleId><ArticleId IdType="pmc">PMC8404831</ArticleId><ArticleId IdType="pubmed">34319150</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarafder S., Khan N. M. (2023). Association of SARS-COV-2 viral RNAemia, IL- 6 gene polymorphism, serum IL-6 and peripheral blood lymphocytes and monocytes with disease severity in COVID-19 patients. Clin. Immunol. 250, 155. doi:&#xa0;10.1016/j.clim.2023.109605</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2023.109605</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardivat Y., Sosnowski P., Tidu A., Westhof E., Eriani G., Martin F. (2023). SARS-CoV-2 NSP1 induces mRNA cleavages on the ribosome. Nucleic Acids Res. 51, 8677&#x2013;8690. doi:&#xa0;10.1093/nar/gkad627</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkad627</ArticleId><ArticleId IdType="pmc">PMC10484668</ArticleId><ArticleId IdType="pubmed">37503833</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavakolian S., Tabaeian S. P., Namazi A., Faghihloo E., Akbari A. (2024). Role of the VEGF in virus-associated cancers. Rev. Med. Virol. 34, e2493. doi:&#xa0;10.1002/rmv.2493</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2493</ArticleId><ArticleId IdType="pubmed">38078693</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y., Zhang Y., Fu X. (2019). &#x3b2; Cell senescence as a common contributor to type 1 and type 2 diabetes. Trends Mol. Med. 25, 735&#x2013;737. doi:&#xa0;10.1016/j.molmed.2019.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2019.07.009</ArticleId><ArticleId IdType="pubmed">31422036</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian W., Zhang N., Jin R., Feng Y., Wang S., Gao S., et al. . (2020). Immune suppression in the early stage of COVID-19 disease. Nat. Commun. 11. doi:&#xa0;10.1038/s41467-020-19706-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19706-9</ArticleId><ArticleId IdType="pmc">PMC7673112</ArticleId><ArticleId IdType="pubmed">33203833</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari R., de la Torre J. C., McGavern D. B., Nayak D. (2019). Beyond tethering the viral particles: Immunomodulatory functions of tetherin (BST-2). DNA Cell Biol. 38, 1170&#x2013;1177. doi:&#xa0;10.1089/dna.2019.4777</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2019.4777</ArticleId><ArticleId IdType="pmc">PMC6939588</ArticleId><ArticleId IdType="pubmed">31502877</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari R., Mishra A. R., Gupta A., Nayak D. (2021). Structural similarity-based prediction of host factors associated with SARS-CoV-2 infection and pathogenesis. J. Biomol Struct. Dyn. 40 (13), 5868&#x2013;5879. doi:&#xa0;10.1080/07391102.2021.1874532</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2021.1874532</ArticleId><ArticleId IdType="pmc">PMC7852281</ArticleId><ArticleId IdType="pubmed">33506741</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong Q., Liu G., Sang X., Zhu X., Fu X., Dou C., et al. . (2023). Targeting RNA G-quadruplex with repurposed drugs blocks SARS-CoV-2 entry. PloS Pathog. 19, e1011131. doi:&#xa0;10.1371/journal.ppat.1011131</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011131</ArticleId><ArticleId IdType="pmc">PMC9904497</ArticleId><ArticleId IdType="pubmed">36701392</ArticleId></ArticleIdList></Reference><Reference><Citation>Touret F., Gilles M., Barral K., Nougairede A., van Helden J., Decroly E., et al. . (2020). In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. Sci. Rep. 10, 13093. doi:&#xa0;10.1038/s41598-020-70143-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-70143-6</ArticleId><ArticleId IdType="pmc">PMC7403393</ArticleId><ArticleId IdType="pubmed">32753646</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukui T., Sun K. H., Wetter J. B., Wilson-Kanamori J. R., Hazelwood L. A., Henderson N. C., et al. . (2020). Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis. Nat. Commun. 11. doi:&#xa0;10.1038/s41467-020-15647-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15647-5</ArticleId><ArticleId IdType="pmc">PMC7174390</ArticleId><ArticleId IdType="pubmed">32317643</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas-Rodriguez J. R., Vald&#xe9;s Aguayo J. J., Garza-Veloz I., Martinez-Rendon J., Del Refugio Rocha Piza&#xf1;a M., Cabral-Pacheco G. A., et al. . (2022). Sustained hyperglycemia and its relationship with the outcome of hospitalized patients with severe COVID-19: Potential role of ACE2 upregulation. J. Pers. Med. 12. doi:&#xa0;10.3390/jpm12050805</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12050805</ArticleId><ArticleId IdType="pmc">PMC9147379</ArticleId><ArticleId IdType="pubmed">35629227</ArticleId></ArticleIdList></Reference><Reference><Citation>Vecchione C., Patrucco E., Marino G., Barberis L., Poulet R., Aretini A., et al. . (2005). Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma. J. Exp. Med. 201, 1217&#x2013;1228. doi:&#xa0;10.1084/jem.20040995</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20040995</ArticleId><ArticleId IdType="pmc">PMC2213159</ArticleId><ArticleId IdType="pubmed">15824082</ArticleId></ArticleIdList></Reference><Reference><Citation>Vial C., Calder&#xf3;n J. F., Klein A. D. (2021). NPC1 as a modulator of disease severity and viral entry of SARS-CoV-2. Curr. Mol. Med. 21, 2&#x2013;4. doi:&#xa0;10.2174/1566524020666200713175426</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566524020666200713175426</ArticleId><ArticleId IdType="pubmed">32660402</ArticleId></ArticleIdList></Reference><Reference><Citation>Vietzen H., Zoufaly A., Traugott M., Aberle J., Aberle S. W., Puchhammer-St&#xf6;ckl E. (2021). Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19. Genet. Med. 23, 963&#x2013;967. doi:&#xa0;10.1038/s41436-020-01077-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41436-020-01077-7</ArticleId><ArticleId IdType="pmc">PMC7835668</ArticleId><ArticleId IdType="pubmed">33500568</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivanti A. J., Vauloup-Fellous C., Prevot S., Zupan V., Suffee C., Do Cao J., et al. . (2020). Transplacental transmission of SARS-CoV-2 infection. Nat. Commun. 11. doi:&#xa0;10.1038/s41467-020-17436-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17436-6</ArticleId><ArticleId IdType="pmc">PMC7360599</ArticleId><ArticleId IdType="pubmed">32665677</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakui H., Tamura K., Tanaka Y., Matsuda M., Bai Y., Dejima T., et al. . (2010). Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice. Hypertension 55, 1157&#x2013;1164. doi:&#xa0;10.1161/HYPERTENSIONAHA.109.147207</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.109.147207</ArticleId><ArticleId IdType="pubmed">20231526</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls A. C., Park Y. J., Tortorici M. A., Wall A., McGuire A. T., Veesler D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281&#x2013;292 e286. doi:&#xa0;10.1016/j.cell.2020.02.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Chen W., Zhang Z., Deng Y., Lian J. Q., Du P., et al. . (2020. b). CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther. 5, 283. doi:&#xa0;10.1038/s41392-020-00426-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00426-x</ArticleId><ArticleId IdType="pmc">PMC7714896</ArticleId><ArticleId IdType="pubmed">33277466</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Kream R. M., Stefano G. B. (2020. a). Long-term respiratory and neurological sequelae of COVID-19. Med. Sci. Monit 26, e928996. doi:&#xa0;10.12659/MSM.928996</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.928996</ArticleId><ArticleId IdType="pmc">PMC7643287</ArticleId><ArticleId IdType="pubmed">33177481</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Li W., Hui H., Tiwari S. K., Zhang Q., Croker B. A., et al. . (2020. c). Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. EMBO J. 39, e106057. doi:&#xa0;10.15252/embj.2020106057</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106057</ArticleId><ArticleId IdType="pmc">PMC7537045</ArticleId><ArticleId IdType="pubmed">32944968</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Qiu Z., Hou Y., Deng X., Xu W., Zheng T., et al. . (2021. c). AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res. 31, 126&#x2013;140. doi:&#xa0;10.1038/s41422-020-00460-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-00460-y</ArticleId><ArticleId IdType="pmc">PMC7791157</ArticleId><ArticleId IdType="pubmed">33420426</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Simoneau C. R., Kulsuptrakul J., Bouhaddou M., Travisano K. A., Hayashi J. M., et al. . (2021. b). Genetic screens identify host factors for SARS-CoV-2 and common cold coronaviruses. Cell 184, 106&#x2013;119.e114. doi:&#xa0;10.1016/j.cell.2020.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.004</ArticleId><ArticleId IdType="pmc">PMC7723770</ArticleId><ArticleId IdType="pubmed">33333024</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Xu X. (2020). scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in spermatogonia, leydig and sertoli cells. Cells 9. doi:&#xa0;10.3390/cells9040920</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9040920</ArticleId><ArticleId IdType="pmc">PMC7226809</ArticleId><ArticleId IdType="pubmed">32283711</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Xu Y., Gao R., Lu R., Han K., Wu G., et al. . (2020. d). Detection of SARS-CoV-2 in different types of clinical specimens. Jama 323, 1843&#x2013;1844. doi:&#xa0;10.1001/jama.2020.3786</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.3786</ArticleId><ArticleId IdType="pmc">PMC7066521</ArticleId><ArticleId IdType="pubmed">32159775</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Zhang M., Garcia G., Jr., Tian E., Cui Q., Chen X., et al. . (2021. a). ApoE-isoform-dependent SARS-CoV-2 neurotropism and cellular response. Cell Stem Cell 28, 331&#x2013;342.e335. doi:&#xa0;10.1016/j.stem.2020.12.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.12.018</ArticleId><ArticleId IdType="pmc">PMC7832490</ArticleId><ArticleId IdType="pubmed">33450186</ArticleId></ArticleIdList></Reference><Reference><Citation>Weglarz-Tomczak E., Tomczak J. M., Talma M., Burda-Grabowska M., Giurg M., Brul S. (2021). Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2. Sci. Rep. 11. doi:&#xa0;10.1038/s41598-021-83229-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-83229-6</ArticleId><ArticleId IdType="pmc">PMC7878891</ArticleId><ArticleId IdType="pubmed">33574416</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J., Alfajaro M. M., DeWeirdt P. C., Hanna R. E., Lu-Culligan W. J., Cai W. L., et al. . (2021). Genome-wide CRISPR screens reveal host factors Critical for SARS-CoV-2 infection. Cell 18476-91, e13. doi:&#xa0;10.1016/j.cell.2020.10.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.028</ArticleId><ArticleId IdType="pmc">PMC7574718</ArticleId><ArticleId IdType="pubmed">33147444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei C., Wan L., Yan Q., Wang X., Zhang J., Yang X., et al. . (2020). HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat. Metab. 2, 1391&#x2013;1400. doi:&#xa0;10.1038/s42255-020-00324-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-020-00324-0</ArticleId><ArticleId IdType="pubmed">33244168</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselink A. K., Hatch E. E., Rothman K. J., Wang T. R., Willis M. D., Yland J., et al. . (2022). A prospective cohort study of COVID-19 vaccination, SARS-CoV-2 infection, and fertility. Am. J. Epidemiol. 191, 1383&#x2013;1395. doi:&#xa0;10.1093/aje/kwac011</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwac011</ArticleId><ArticleId IdType="pmc">PMC8807200</ArticleId><ArticleId IdType="pubmed">35051292</ArticleId></ArticleIdList></Reference><Reference><Citation>White J. M., Delos S. E., Brecher M., Schornberg K. (2008). Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 43, 189&#x2013;219. doi:&#xa0;10.1080/10409230802058320</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10409230802058320</ArticleId><ArticleId IdType="pmc">PMC2649671</ArticleId><ArticleId IdType="pubmed">18568847</ArticleId></ArticleIdList></Reference><Reference><Citation>White K. M., Rosales R., Yildiz S., Kehrer T., Miorin L., Moreno E., et al. . (2021). Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. Science 371, 926&#x2013;931. doi:&#xa0;10.1126/science.abf4058</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf4058</ArticleId><ArticleId IdType="pmc">PMC7963220</ArticleId><ArticleId IdType="pubmed">33495306</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff G., Limpens R., Zevenhoven-Dobbe J. C., Laugks U., Zheng S., de Jong A. W. M., et al. . (2020). A molecular pore spans the double membrane of the coronavirus replication organelle. Science 369, 1395&#x2013;1398. doi:&#xa0;10.1126/science.abd3629</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3629</ArticleId><ArticleId IdType="pmc">PMC7665310</ArticleId><ArticleId IdType="pubmed">32763915</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Chen L., Qin C., Huo F., Liang X., Yang X., et al. . (2022). CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis. Signal Transduct Target Ther. 7, 382. doi:&#xa0;10.1038/s41392-022-01230-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01230-5</ArticleId><ArticleId IdType="pmc">PMC9691700</ArticleId><ArticleId IdType="pubmed">36424379</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C. T., Lidsky P. V., Xiao Y., Lee I. T., Cheng R., Nakayama T., et al. . (2021. a). SARS-CoV-2 infects human pancreatic &#x3b2; cells and elicits &#x3b2; cell impairment. Cell Metab. 33, 1565&#x2013;1576.e1565. doi:&#xa0;10.1016/j.cmet.2021.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.05.013</ArticleId><ArticleId IdType="pmc">PMC8130512</ArticleId><ArticleId IdType="pubmed">34081912</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Ma L., Cai S., Zhuang Z., Zhao Z., Jin S., et al. . (2021. b). RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-&#x3ba;B hyper-activation and inflammation. Signal Transduct Target Ther. 6, 167. doi:&#xa0;10.1038/s41392-021-00575-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00575-7</ArticleId><ArticleId IdType="pmc">PMC8065320</ArticleId><ArticleId IdType="pubmed">33895773</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyler E., M&#xf6;sbauer K., Franke V., Diag A., Gottula L. T., Arsi&#xe8; R., et al. . (2021). Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy. iScience 24, 102151. doi:&#xa0;10.1016/j.isci.2021.102151</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102151</ArticleId><ArticleId IdType="pmc">PMC7866843</ArticleId><ArticleId IdType="pubmed">33585804</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Cao Z., Xie X., Zhang X., Chen J. Y., Wang H., et al. . (2020). Evasion of type I interferon by SARS-CoV-2. Cell Rep. 33, 108234. doi:&#xa0;10.1016/j.celrep.2020.108234</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108234</ArticleId><ArticleId IdType="pmc">PMC7501843</ArticleId><ArticleId IdType="pubmed">32979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia B., Pan X., Luo R. H., Shen X., Li S., Wang Y., et al. . (2023). Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2. Cell Discovery 9, 2. doi:&#xa0;10.1038/s41421-022-00510-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-022-00510-2</ArticleId><ArticleId IdType="pmc">PMC9821354</ArticleId><ArticleId IdType="pubmed">36609376</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Al-Aly Z. (2022). Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 10, 311&#x2013;321. doi:&#xa0;10.1016/S2213-8587(22)00044-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. (2022). Long-term cardiovascular outcomes of COVID-19. Nat. Med. 28, 583&#x2013;590. doi:&#xa0;10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong N., Sun Q. (2023). How does SARS-CoV-2 infection impact on immunity, procession and treatment of pan cancers. J. Med. Virol. 95, e28487. doi:&#xa0;10.1002/jmv.28487</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28487</ArticleId><ArticleId IdType="pubmed">36625395</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong R., Zhang L., Li S., Sun Y., Ding M., Wang Y., et al. . (2020). Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Protein Cell 11, 723&#x2013;739. doi:&#xa0;10.1007/s13238-020-00768-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-020-00768-w</ArticleId><ArticleId IdType="pmc">PMC7402641</ArticleId><ArticleId IdType="pubmed">32754890</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H., Du X., Xu J., Zhang Y., Tian Y., Liu G., et al. . (2020). Pancreatic &#x3b2; cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving &#x3b2; cell function. PloS Biol. 18, e3000603. doi:&#xa0;10.1371/journal.pbio.3000603</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000603</ArticleId><ArticleId IdType="pmc">PMC7058362</ArticleId><ArticleId IdType="pubmed">32092075</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., et al. . (2020. b). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 8, 420&#x2013;422. doi:&#xa0;10.1016/S2213-2600(20)30076-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Xu X., Jiang L., Dua K., Hansbro P. M., Liu G. (2020. a). SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis. Respir. Res. 21, 182. doi:&#xa0;10.1186/s12931-020-01445-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01445-6</ArticleId><ArticleId IdType="pmc">PMC7359430</ArticleId><ArticleId IdType="pubmed">32664949</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu P., Ye S., Li K., Huang M., Wang Q., Zeng S., et al. . (2019). NOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2. J. Exp. Clin. Cancer Res. 38, 483. doi:&#xa0;10.1186/s13046-019-1448-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13046-019-1448-9</ArticleId><ArticleId IdType="pmc">PMC6896289</ArticleId><ArticleId IdType="pubmed">31805977</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan B., Freiwald T., Chauss D., Wang L., West E., Mirabelli C., et al. . (2021). SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation. Sci. Immunol. 6 (58), eabg0833. doi:&#xa0;10.1126/sciimmunol.abg0833</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abg0833</ArticleId><ArticleId IdType="pmc">PMC8139422</ArticleId><ArticleId IdType="pubmed">33827897</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan W., Zheng Y., Zeng X., He B., Cheng W. (2022). Structural biology of SARS-CoV-2: open the door for novel therapies. Signal Transduct Target Ther. 7, 26. doi:&#xa0;10.1038/s41392-022-00884-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00884-5</ArticleId><ArticleId IdType="pmc">PMC8793099</ArticleId><ArticleId IdType="pubmed">35087058</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y., Sun H., Chen Y., Tian L., Huang D., Liu C., et al. . (2023). RBM24 inhibits the translation of SARS-CoV-2 polyproteins by targeting the 5&#x2019;-untranslated region. Antiviral Res. 209, 105478. doi:&#xa0;10.1016/j.antiviral.2022.105478</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2022.105478</ArticleId><ArticleId IdType="pmc">PMC9712144</ArticleId><ArticleId IdType="pubmed">36464077</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi R., Hashimoto R., Sakamoto A., Matsumura Y., Nagao M., Takahashi K., et al. . (2022). Exocyst complex component 2 is a potential host factor for SARS-CoV-2 infection. iScience 25, 105427. doi:&#xa0;10.1016/j.isci.2022.105427</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105427</ArticleId><ArticleId IdType="pmc">PMC9595492</ArticleId><ArticleId IdType="pubmed">36310645</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousefi H., Poursheikhani A., Bahmanpour Z., Vatanmakanian M., Taheri M., Mashouri L., et al. . (2020). SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach. BioMed. Pharmacother. 130, 110548. doi:&#xa0;10.1016/j.biopha.2020.110548</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110548</ArticleId><ArticleId IdType="pmc">PMC7386606</ArticleId><ArticleId IdType="pubmed">33475497</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S., Hu H., Ai Q., Bai R., Ma K., Zhou M., et al. . (2023). SARS-CoV-2 spike-mediated entry and its regulation by host innate immunity. Viruses 15. doi:&#xa0;10.3390/v15030639</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030639</ArticleId><ArticleId IdType="pmc">PMC10059852</ArticleId><ArticleId IdType="pubmed">36992348</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandi M., Shafaati M., Kalantar-Neyestanaki D., Pourghadamyari H., Fani M., Soltani S., et al. . (2022). The role of SARS-CoV-2 accessory proteins in immune evasion. BioMed. Pharmacother. 156, 113889. doi:&#xa0;10.1016/j.biopha.2022.113889</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.113889</ArticleId><ArticleId IdType="pmc">PMC9574935</ArticleId><ArticleId IdType="pubmed">36265309</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang R., Gomez Castro M. F., McCune B. T., Zeng Q., Rothlauf P. W., Sonnek N. M., et al. . (2020). TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci. Immunol. 5. doi:&#xa0;10.1126/sciimmunol.abc3582</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abc3582</ArticleId><ArticleId IdType="pmc">PMC7285829</ArticleId><ArticleId IdType="pubmed">32404436</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Amahong K., Sun X., Lian X., Liu J., Sun H., et al. . (2021. c). The miRNA: a small but powerful RNA for COVID-19. Brief Bioinform. 22, 1137&#x2013;1149. doi:&#xa0;10.1093/bib/bbab062</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbab062</ArticleId><ArticleId IdType="pmc">PMC7989616</ArticleId><ArticleId IdType="pubmed">33675361</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Chen Z., Huang C., Sun J., Xue M., Feng T., et al. . (2021. b). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) and spike (S) proteins antagonize host type I interferon response. Front. Cell Infect. Microbiol. 11. doi:&#xa0;10.3389/fcimb.2021.766922</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.766922</ArticleId><ArticleId IdType="pmc">PMC8688923</ArticleId><ArticleId IdType="pubmed">34950606</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen Y., Li Y., Huang F., Luo B., Yuan Y., et al. . (2021. d). The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-&#x3b9;. Proc. Natl. Acad. Sci. U.S.A. 118. doi:&#xa0;10.1073/pnas.2024202118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024202118</ArticleId><ArticleId IdType="pmc">PMC8201919</ArticleId><ArticleId IdType="pubmed">34021074</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Ma Q., Yu Q., Xiao F., Zhang Z., Feng H., et al. . (2023). PSMD3-ILF3 signaling cascade drives lung cancer cell proliferation and migration. Biol. Direct 18, 33. doi:&#xa0;10.1186/s13062-023-00389-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13062-023-00389-3</ArticleId><ArticleId IdType="pmc">PMC10278297</ArticleId><ArticleId IdType="pubmed">37337223</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Miorin L., Makio T., Dehghan I., Gao S., Xie Y., et al. . (2021. a). Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression. Sci. Adv. 7. doi:&#xa0;10.1126/sciadv.abe7386</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abe7386</ArticleId><ArticleId IdType="pmc">PMC7864571</ArticleId><ArticleId IdType="pubmed">33547084</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Nomura N., Muramoto Y., Ekimoto T., Uemura T., Liu K., et al. . (2022. b). Structure of SARS-CoV-2 membrane protein essential for virus assembly. Nat. Commun. 13. doi:&#xa0;10.1038/s41467-022-32019-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32019-3</ArticleId><ArticleId IdType="pmc">PMC9355944</ArticleId><ArticleId IdType="pubmed">35931673</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Shao L., Lin Z., Long Q. X., Yuan H., Cai L., et al. . (2022. a). APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients. Signal Transduct Target Ther. 7, 261. doi:&#xa0;10.1038/s41392-022-01118-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01118-4</ArticleId><ArticleId IdType="pmc">PMC9340718</ArticleId><ArticleId IdType="pubmed">35915083</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Shi L., Wang F. S. (2020). Liver injury in COVID-19: management and challenges. Lancet Gastroenterol. Hepatol. 5, 428&#x2013;430. doi:&#xa0;10.1016/S2468-1253(20)30057-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30057-1</ArticleId><ArticleId IdType="pmc">PMC7129165</ArticleId><ArticleId IdType="pubmed">32145190</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Zhou Q., Dorfman R. G., Huang X., Fan T., Zhang H., et al. . (2016). Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats. BMC Gastroenterol. 16, 84. doi:&#xa0;10.1186/s12876-016-0500-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-016-0500-x</ArticleId><ArticleId IdType="pmc">PMC4967301</ArticleId><ArticleId IdType="pubmed">27473867</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H., Lu L., Peng Z., Chen L. L., Meng X., Zhang C., et al. . (2022). SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerg. Microbes Infect. 11, 277&#x2013;283. doi:&#xa0;10.1080/22221751.2021.2023329</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.2023329</ArticleId><ArticleId IdType="pmc">PMC8774049</ArticleId><ArticleId IdType="pubmed">34951565</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B., Ni C., Gao R., Wang Y., Yang L., Wei J., et al. . (2020). Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids. Protein Cell 11, 771&#x2013;775. doi:&#xa0;10.1007/s13238-020-00718-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-020-00718-6</ArticleId><ArticleId IdType="pmc">PMC7164704</ArticleId><ArticleId IdType="pubmed">32303993</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X., Nicholls J. M., Chen Y. G. (2008). Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling. J. Biol. Chem. 283, 3272&#x2013;3280. doi:&#xa0;10.1074/jbc.M708033200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M708033200</ArticleId><ArticleId IdType="pmc">PMC8740907</ArticleId><ArticleId IdType="pubmed">18055455</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Deng J., Han L., Zhuang M. W., Xu Y., Zhang J., et al. . (2022). SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules. Signal Transduct Target Ther. 7, 22. doi:&#xa0;10.1038/s41392-022-00878-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00878-3</ArticleId><ArticleId IdType="pmc">PMC8785035</ArticleId><ArticleId IdType="pubmed">35075101</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y. Y., Ma Y. T., Zhang J. Y., Xie X. (2020). COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 17, 259&#x2013;260. doi:&#xa0;10.1038/s41569-020-0360-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0360-5</ArticleId><ArticleId IdType="pmc">PMC7095524</ArticleId><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X., Wang X., Tu F., Wang Q., Fan Z., Gao G. (2017). TRIM25 is required for the antiviral activity of zinc finger antiviral protein. J. Virol. 91. doi:&#xa0;10.1128/JVI.00088-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00088-17</ArticleId><ArticleId IdType="pmc">PMC5391446</ArticleId><ArticleId IdType="pubmed">28202764</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Liu Y., Gupta S., Paramo M. I., Hou Y., Mao C., et al. . (2023). A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. Nat. Biotechnol. 41, 128&#x2013;139. doi:&#xa0;10.1038/s41587-022-01474-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-022-01474-0</ArticleId><ArticleId IdType="pmc">PMC9851973</ArticleId><ArticleId IdType="pubmed">36217030</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Wan Q., Chen S., Chen Y., Wang P. H., Yao X., et al. . (2021). Attenuating innate immunity and facilitating &#x3b2;-coronavirus infection by NSP1 of SARS-CoV-2 through specific redistributing hnRNP A2/B1 cellular localization. Signal Transduct Target Ther. 6, 371. doi:&#xa0;10.1038/s41392-021-00786-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00786-y</ArticleId><ArticleId IdType="pmc">PMC8546379</ArticleId><ArticleId IdType="pubmed">34702797</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Xu W., Liu Z., Wang C., Xia S., Lan Q., et al. . (2022). A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases. Acta Pharm. Sin. B 12, 1652&#x2013;1661. doi:&#xa0;10.1016/j.apsb.2021.07.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2021.07.026</ArticleId><ArticleId IdType="pmc">PMC8327648</ArticleId><ArticleId IdType="pubmed">34367893</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Paul W. E. (2008). CD4 T cells: fates, functions, and faults. Blood 112, 1557&#x2013;1569. doi:&#xa0;10.1182/blood-2008-05-078154</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2008-05-078154</ArticleId><ArticleId IdType="pmc">PMC2518872</ArticleId><ArticleId IdType="pubmed">18725574</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L., She Z. G., Cheng X., Qin J. J., Zhang X. J., Cai J., et al. . (2020). Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 31, 1068&#x2013;1077.e1063. doi:&#xa0;10.1016/j.cmet.2020.04.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7252168</ArticleId><ArticleId IdType="pubmed">32369736</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler C. G. K., Allon S. J., Nyquist S. K., Mbano I. M., Miao V. N., Tzouanas C. N., et al. . (2020). SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181, 1016&#x2013;1035.e1019. doi:&#xa0;10.1016/j.cell.2020.04.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.035</ArticleId><ArticleId IdType="pmc">PMC7252096</ArticleId><ArticleId IdType="pubmed">32413319</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou S., Chen S., Rao G., Zhang G., Ma M., Peng B., et al. . (2024). Extrachromosomal circular MiR-17-92 amplicon promotes HCC. Hepatology 79, 79&#x2013;95. doi:&#xa0;10.1097/HEP.0000000000000435</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HEP.0000000000000435</ArticleId><ArticleId IdType="pubmed">37125628</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G. C. Y., Yeoh Y. K., Li A. Y. L., Zhan H., et al. . (2020). Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology 159, 944&#x2013;955.e948. doi:&#xa0;10.1053/j.gastro.2020.05.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>